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 ABSTRACT 
A TEMPERATURE SENSITIVE MUTATION IN CACTIN CAUSES 
A G1 PHASE ARREST IN TOXOPLASMA GONDII 
Tomasz A. Szatanek 
Thesis Advisor: Professor Marc-Jan Gubbels 
 
The length of the tachyzoite cell cycle, in particular G1, is an important virulence 
factor in Toxoplasma gondii. Cdk and Cyclin activities ultimately control the cell 
cycle; however, the checkpoint control mechanisms diverge from higher 
eukaryotes and are poorly understood. In order to elucidate these mechanisms, 
temperature sensitive (ts) mutants were generated by chemical mutagenesis. 
One of these mutants, called FV-P6, dies within one cell cycle in the G1 phase 
upon transfer from the permissive (35°C) to the restrictive temperature (40°C). 
Cosmid complementation identified the gene responsible for this G1 arrest as a 
‘Cactin’ ortholog. A single point mutation in this gene that resulted in an amino 
acid substitution from Tyrosine to Histidine at position 661 in the highly 
conserved C-terminus was shown to underlay the temperature sensitive effect.  
Cactin is highly conserved across eukaryotes and plays a role in embryonic 
development of metazoa although its mechanism of action is poorly understood. 
In agreement with the predicted nuclear localization signal in the N-terminus, 
expression of a fluorescent reporter gene fusion resulted in nuclear localization. 
Genome-wide expression profiling analysis of mutant and wild type at the 
permissive and restrictive temperatures confirmed the G1 arrest and furthermore 
demonstrated up-regulation of bradyzoite and Toxoplasma cat life cycle stage 
genes, hinting at TgCactin’s role as a repressor. Since DNA binding domains or 
enzymatic domains are absent in TgCactin, TgCactin must act in a complex. 
Native blue gel electrophoresis demonstrated that TgCactin is present in large 
complexes of 720 and 800 kDa.  A yeast two-hybrid screen (YTH) identified 40 
potential TgCactin-interacting proteins of which 10 were selected for further 
 validation. Eight out of these ten candidates are involved in DNA/RNA processes 
pertaining to transcription and translation, respectively. One-on-one YTH 
interactions between mutated and N-terminal deletion mutants of TgCactin and 
the above 10 interactors were abolished except for a single RNA helicase. 
Studies in Toxoplasma of four of these interactors demonstrated that only the 
RNA helicase localized to the nucleus; however, co-immunoprecipitation 
experiments to demonstrate that this protein is present in a complex with 
TgCactin were inconclusive. Furthermore, TgCactin self interactions identified 
domains necessary for TgCactin-TgCactin binding. Taken together, these 
findings indicate that TgCactin likely functions as a repressor of gene expression, 
possibly through an epigenetic mechanism reminiscent of an RNA/DNA helicase- 
based system in plants. 
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A1. General background 
The phylum Apicomplexa comprises 5000 species of obligate intracellular 
parasites. Many of these parasites cause diseases affecting humans as well as 
animals, including several with high mortality rates and a negative impact on the 
economy (Levine, 1988). Members of this phylum include Toxoplasma gondii, 
which causes encephalitis and birth defects, Plasmodium species (spp.), which 
cause malaria and kill nearly 2 million people per year, mostly children under the 
age of 5 (Haldar and Mohandas, 2009), Eimeria spp., pathogens of chicken and 
cattle (Shirley et al., 2005), Cryptosporidium spp., pathogens of animals but also 
an opportunistic human parasite that causes acute gastroenteritis and diarrhea 
(Tzipori and Ward, 2002) and Theileria and Babesia spp., tick-borne parasites 
infecting various ruminants including goats, sheep and cattle (Shaw, 2003).  
 
Transmission of Toxoplasma  
Worldwide, Toxoplasma gondii infection rates range from 10 to 90% (Montoya 
and Liesenfeld, 2004) with about 25% of Americans being infected (Jones et al., 
2001). Cats are considered as the definitive hosts in which sexual reproduction 
occurs within the intestinal epithelium, giving rise to oocysts, which are shed 
within the feces. Any warm-blooded animal can serve as an intermediate host. 
Intermediate hosts are infected upon ingestion of cat feces-contaminated water 
or food (Frenkel et al., 1970) (Fig. 1-1A). The parasite disseminates throughout 
the body and invades nucleated cells. Toxoplasma exists in two distinct life 
stages in the intermediate host, namely rapidly dividing tachyzoites and slow 
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growing bradyzoites (Ferguson, 2004), representing acute and chronic infection, 
respectively. Acute infection occurs in absence of immune pressure when an 
individual acquires Toxoplasma for the first time through the ingestion of oocysts 
contaminated water or food. In addition intermediate hosts can become infected 
through a horizontal transmission route, i.e., through the consumption of raw or 
undercooked meat containing bradyzoite cysts from another intermediate host 
(Montoya and Liesenfeld, 2004) (Fig. 1-1B). Furthermore, upon loss of immunity, 
bradyzoites convert back into tachyzoites with all symptoms of an acute infection. 
The mounting adaptive immune response of a healthy individual forces the 
differentiation of the actively dividing tachyzoites into the latent, metabolically 
inactive bradyzoites (Frenkel, 1973). Bradyzoites reside in nervous and muscular 
tissues and are maintained for the life of the host. 
 
Clinical presentation of toxoplasmosis 
In healthy individuals, infection with Toxoplasma can go unnoticed or depending 
on immune status of the patient, can manifest itself with flu-like symptoms such 
as swollen glands, muscle aches, fatigue, fever, sore throat or skin rash 
(Montoya and Liesenfeld, 2004). The damage of an acute infection in 
immunocompetent patients is curbed by the adaptive immune response, which 
causes stage conversion into latent bradyzoites. The immune system cannot 
clear this chronic infection; and the infection is maintained throughout the 
lifespan of the host, but a chronic bradyzoite infection does not pose a health 
risk. However, when the immune system is compromised, recrudescence of a 
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latent infection can occur (Montoya and Liesenfeld, 2004). The groups at risk are 
immunocompromised individuals such as AIDS, cancer or organ transplant 
patients (Luft and Remington, 1992; Montoya and Liesenfeld, 2004). In such 
hosts, the immune pressure responsible for inducing stage conversion to 
bradyzoites is absent enabling the acute infection to flourish with rampant 
tachyzoite proliferation. In these cases toxoplasmosis manifests itself by 
intracerebral lesions resulting in encephalitis, or when in the heart as myocarditis, 
both of which, eventually result in death (Montoya and Liesenfeld, 2004). Tissue 
damage by acute stage replication is exacerbated by a strong inflammatory 
response as host cells are being destroyed. 
 
Toxoplasma is also a leading cause of congenital defects in humans (Wallon et 
al., 2001). Tachyzoites can traverse the placenta causing congenital infection, 
which can lead to a wide array of clinical manifestations ranging from no 
symptoms, abortion, fetal death, hydrocephalus, microcephaly, seizures, mental 
retardation, and retinochoroiditis (Kodjikian et al., 2006). Severity of symptoms 
correlates with the length of gestation prior to infection with early infection being 
most damaging to the fetus. Infections that are asymptomatic at birth can 
manifest themselves later in life with blindness (retinochoroiditis) and brain 
damage (e.g., seizures). Congenital toxoplasmosis can be diagnosed with 
ultrasound by observing ventricular dilation, hepatic enlargement, ascites, and 
increased placental thickness (Kodjikian et al., 2006). Prenatal diagnosis is 
determined based on PCR of amniotic fluid (Gay-Andrieu et al., 2003).  
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Treatment of toxoplasmosis 
Current drug treatments target only the acute phase of toxoplasmosis. The 
primary drugs consist of pyrimethamine, sulphonamides, spiramycin, 
clindamycin, steroids, and corticosteroids (Montoya and Liesenfeld, 2004). At 
present, a cocktail of sulfadiazine, pyrimethamine and folinic acid are the 
standard care for acute toxoplasmosis (Montoya and Liesenfeld, 2004). In animal 
models, atovaquone and azithromycin have demonstrated promising results in 
being partially effective against tissue cysts (Huskinson-Mark et al., 1991; 
Derouin et al., 1992). 
 
Cell biology of Toxoplasma 
The crescent-like shape of Toxoplasma is conferred by the pellicle, a thin layer 
supporting the cell membrane. The pellicle consists of the inner membrane 
complex (IMC) (Foussard et al., 1990) and the subpellicular microtubules. The 
latter run down about two thirds of the length of the parasite along the cytosolic 
face of the IMC (Nichols and Chiappino, 1987). The IMC is composed of 
flattened membrane sacs called alveoli, which are stabilized by a protein 
meshwork of intermediate filaments associated with its inner membrane (Mann 
and Beckers, 2001; Morrissette and Sibley, 2002b; Anderson-White et al., 2010). 
The structural integrity of the parasite’s shape is maintained by its cortical 
cytoskeleton made up of intermediate filament-like proteins (Morrissette and 
Sibley, 2002a). 
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As do all apicomplexans, Toxoplasma has a group of specialized structures at 
the apical end called the apical complex. These structures include two secretory 
organelles: the micronemes and the rhoptries, which are implicated in parasite 
motility, adhesion and invasion of host cells, and establishment of the 
parasitophorous vacuole (PV) (Carruthers and Sibley, 1997; Carruthers et al., 
1999; Hu et al., 2006). An additional apical organelle is the conoid, a tightly 
wound basket of tubulin polymers that protrudes from the parasite during host 
cell invasion and is involved in invasion (Black and Boothroyd, 2000; Hu et al., 
2002). Furthermore, three polar rings are located apically, of which one serves as 
the microtubule organizing center (MTOC) of the subpellicular microtubules (Hu 
et al., 2006). An additional MTOC is provided by the spindle pole plaques or 
centrosomes, which guide mitosis and cell division. During mitosis, the 14 
chromosomes exhibit little condensation while the nuclear envelope stays intact. 
The spindle microtubules, originating in the centrosomes, traverse the nuclear 
envelope in a specialized structure named the centrocone (Nichols and 
Chiappino, 1987; Gubbels et al., 2006). Interestingly, the centrocone or spindle 
pole is maintained throughout the entire cell cycle (Gubbels et al., 2006). 
  
B1. Life cycle and cell division of Toxoplasma 
Life cycle of Toxoplasma gondii 
Asexual cell cycle 
The asexual cycle starts when ingested bradyzoites or sporozoites are released 
in the host gut from cysts (Frenkel, 1973) or oocysts (Dubey et al., 1970), 
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respectively. The released parasites invade intestinal epithelia and transform into 
rapidly growing tachyzoite forms, which disseminate via the blood stream to 
various tissues such as the central nervous system, eye, skeletal and heart 
muscle (Montoya and Liesenfeld, 2004). During acute infection, tachyzoites 
invade nucleated host cells and use the host cell membrane to establish a 
parasitophorous vacuole (PV) (Suss-Toby et al., 1996; Dubremetz et al., 1998). 
Within the PV, the tachyzoites undergo replication by an internal budding 
mechanism called endodyogeny (Fig. 1-3), giving rise to two daughter cells per 
mother cell (Goldman et al., 1958). The division continues until the enlarging 
vacuole fills the free space in the cell. At that point, the parasites egress to 
liberate the multiplied tachyzoites, which go on to invade adjacent host cells and 
the cycle repeats itself. In order to guarantee T. gondii does not kill its host, 
parasites differentiate into the latent bradyzoites, triggered by the mounting 
immune response (Frenkel, 1973; Lyons et al., 2002). Bradyzoites form tissue 
cysts mostly in brain cells and muscle tissues where they persist for the lifetime 
of the host. While tachyzoites and bradyzoites are almost identical, except for the 
more basally located nucleus in the bradyzoites, the bradyzoite division rate is 
much slower and they often divide asynchronously, both through endodyogeny 
and endopolygeny (repeated rounds of nuclear division followed by a final round 
of mitosis coupled with initiation of multiple daughters within the cytoplasm) 
(Dzierszinski et al., 2004; Ferguson et al., 2007). 
 
 Sexual cell cycle 
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The sexual stages develop only in cats when they ingest bradyzoite-infected 
tissue. The cyst wall is dissolved and released bradyzoites penetrate the feline 
small intestine epithelia wherein they undergo rounds of endopolygeny before 
giving rise to micro- and macro-gametes (Dubey and Frenkel, 1976). A 
microgamete fertilizes a macrogamete, giving rise to the formation of a zygote, 
which ultimately differentiates into an oocyst. The oocysts are shed into the 
environment with the cat feces where they undergo sporulation, resulting in 
sporozoites. Sporulated oocysts are in turn ingested by intermediate hosts and 
transform into tachyzoites, which completes the life cycle (Dubey et al., 1970).  
 
Differential gene expression in stage conversion  
Tachyzoite to bradyzoite transition is manifested by changes in gene expression, 
i.e. there are genes expressed only in bradyzoites or only in tachyzoites (Lunde 
and Jacobs, 1983). The first set of genes that was identified to be differentially 
expressed between these stages was glycosylphosphatidylinositol (GPI)-
anchored surface antigen proteins, the so-called SAG1-related sequences (SRS) 
(Nagel and Boothroyd, 1989; Tomavo et al., 1989; Lekutis et al., 2001). SAG1 is 
exclusively expressed in tachyzoites, whereas SAG4 (Tomavo et al., 1991) and 
BSR4 (Tomavo et al., 1991; Knoll and Boothroyd, 1998) are expressed in 
bradyzoites only. One of the features of the bradyzoite is a cyst wall, which 
contains CST1, a 116 kDa glycoprotein that is recognized by the lectin Dolichos 
biflorus antigen (DBA) (Boothroyd et al., 1997). The thick cyst wall protects the 
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bradyzoites from the immune system. An immune response is mounted against 
some of the SRS proteins of tachyzoites (Tomavo, 1996).  
 
Genome-wide expression profiles of bradyzoites demonstrated that bradyzoite 
differentiation induced in vitro by either Compound 1 (Radke et al., 2006) or 
alkaline conditions (Soete et al., 1994) enhance not only expression of common 
bradyzoite genes but also genes unique to each condition (Behnke et al., 2008). 
Furthermore, the promoter regions of bradyzoite genes possess cis-regulatory 
elements that are needed for bradyzoite differentiation (Behnke et al., 2008). 
Also, it has been noted that some bradyzoite specific promoter regions are 
hyperacetylated during differentiation (Saksouk et al., 2005). These results imply 
that bradyzoite differentiation might be accomplished through the combination of 
epigenetic and cis-regulatory elements.   
 
The third stage found in the intermediate host, sporozoites, do express their own 
set of SRS proteins as well: e.g., SporoSAG (Kasper et al., 1984) (Radke et al., 
2004). However, sporozoites, like tachyzoites, express SAG1, SRS3, and SAG3 
(Lekutis et al., 2001; Radke et al., 2004). In contrast, sporozoites do not express 
nucleoside triphosphate hydrolases (NTPases) (Bermudes et al., 1994) and  
dense granule protein GRA3 (Speer et al., 1997), which are found in both 
tachyzoites and bradyzoites. These results imply that each developmental stage 
of Toxoplasma gondii has its own set of unique genes specific to tachyzoites, 
sporozoites, and bradyzoites.  
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Although the gene expression patterns of the gametocytes cannot be assessed 
directly in Toxoplasma since these stages are not accessible (they are only 
detected in low numbers in the cat intestine), orthologous stages in Plasmodium 
falciparum have been extensively studied. These studies have identified various 
surface markers expressed in conjunction with the various sexual developmental 
stages (Sinden, 2009). For instance, membrane protein Pfs16 persists 
throughout the entirety of gametocyte development (Bruce et al., 1994). Some 
other proteins that are expressed during later stages of gametocytes are Pfpeg3, 
Pfpeg4 (Silvestrini et al., 2005), and Pfg27 (Carter et al., 1989). Overall, 
proteomic studies of Plasmodium falciparum proteins have shown that 315 of 
these are gametocyte-specific whereas 97 were gamete- specific (Lasonder et 
al., 2002). Furthermore, the sex-specific study of the Plasmodium berghei 
proteome demonstrated that 600 proteins are specific to either male of female 
gametocytes (Khan et al., 2005) demonstrating the individual roles of the two 
sexes. Taken together these findings imply that the stage conversion in 
Plasmodia, and most likely in other Apicomplexa, is accompanied by significant 
changes in gene specific expression. 
 
Differential gene expression in tachyzoite development 
Genome-wide expression array analysis of synchronized tachyzoites through the 
cell cycle revealed two subtranscriptomes, G1 and S/M, with compartmentalized 
gene expression profiles (Behnke et al., 2010). As in higher eukaryotes, the G1-
subtranscriptome encompasses genes that are involved in basal biosynthetic and 
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metabolic functions such as transcription, translation and ribosomal biogenesis 
proteins (Behnke et al., 2010). On the other hand, the S/M-subtranscriptome has 
genes unique to Toxoplasma, which are involved in cell growth, invasion, motility 
and egress (Behnke et al., 2010).  
 
Features and timing of cell division in Toxoplasma gondii 
The Toxoplasma tachyzoite cell division cycle encompasses 6-8 hrs and is 
comprised of three distinct phases (Radke et al., 2001): most time is spent in the 
G1 phase (60%), followed by S phase (30%); and in the third phase mitosis is 
coupled with cytokinesis (10%) (Fig.1-3). It appears that the G2 phase that often 
occurs between S phase and mitosis is non-existent or 20 minutes long at best 
even though DNA replication is only 90% complete at this point (Radke and 
White, 1998; Radke et al., 2001). In contrast to higher eukaryotic cell cycles, 
daughter budding is initiated during late S phase when DNA content is at 1.8 N 
(Hu et al., 2004).  
 
One of the earliest events taking place in tachyzoite G1 is widening and division 
of the Golgi apparatus (Pelletier et al., 2002). It appears that Golgi replication is 
intimately connected with the migration and duplication of the centrosome 
(Hartmann et al., 2006). During interphase, the centrosome is localized next to 
the Golgi at the apical side of the nucleus. Prior to centrosome duplication, the 
centrosome migrates to the basal end of the nucleus and upon division, the 
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centrosomes return to the apical side and associate with the outer ends of the 
already-duplicated Golgi (Hartmann et al., 2006).  
 
The duplication of centrosomes marks commitment of Toxoplasma to DNA 
replication and entry into S phase (White et al., 2005). The migration of 
duplicated centrosomes back to the apical end is one of the events that take 
place in S phase. DNA replication can be visualized with antibodies against or 
fluorescent protein fusions of the Toxoplasma proliferating cell nuclear antigen 1 
(PCNA1) (Guerini et al., 2000; Guerini et al., 2005). PCNA1 is concentrated in 
the nucleus throughout duration of the cell cycle and displays a punctate pattern 
indicative of replication foci during S phase (Guerini et al., 2005). The entire 
process of DNA synthesis takes about 20 to 30 min (Radke et al., 2001). When 
tachyzoites reach about 1.8 N nuclear DNA content, replication pauses or slows 
down (the putative G2 phase). During that time the spindle pole duplicates and 
the spindle forms followed by completion of chromosome replication. This is 
followed by the appearance of the two daughter buds in the proximity of the 
centrosome (Radke et al., 2001; White et al., 2005). 
 
As mentioned earlier, the spindle poles are embedded in the nuclear envelope 
and are termed centrocones (Dubremetz, 1973; Gubbels et al., 2006). The 
microtubules converge on the cytoplasmic side, run through the centrocone, and 
penetrate the nuclear envelope. A marker for the centrocone is the membrane 
occupation and recognition nexus protein 1 (MORN1) (Gubbels et al., 2006). 
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Interestingly, the spindle pole persists throughout the cell cycle (Dubremetz, 
1973; Vaishnava et al., 2005). Upon mitosis, the spindle pole duplicates within 
the nuclear envelope and the two poles migrate apart with the help of 
microtubules forming between the poles (Gubbels et al., 2006). The spindle poles 
do not migrate completely to opposite sides but remain on the apical side of the 
nucleus at a “10-past-10” angle (Gubbels et al., 2008b). Mitosis in Toxoplasma 
takes place within boundaries of the nuclear envelope, which does not 
disassemble as in higher eukaryotes (Lohka and Maller, 1985). During later 
stages of division, the nucleus adopts a characteristic U-shaped intermediate 
morphology before completing karyokinesis (Radke et al., 2001).  
 
The last stage of tachyzoite cell division, cytokinesis, is closely linked with 
mitosis. Cytokinesis unfolds through endodyogeny, which is defined by internal 
budding and is driven by the assembly of the daughter cytoskeleton (Sheffield 
and Melton, 1968; Striepen et al., 2007). Growth of the cytoskeleton, which 
consists of subpellicular microtubules and the IMC, is driven by microtubular 
assembly processes or by microtubule-based motor proteins (Hu, 2008) in 
conjunction with an actin-like protein (ALP1) (Gordon et al., 2008; Hu, 2008). At 
the late stage of budding, Centrin2 is recruited to the basal complex, which also 
contains MORN1, and IMC proteins 5, 8, 9, 13, and 15 (Hu, 2008; Anderson-
White et al., 2010). The basal complex constricts resulting in tapering of the 
forming cytoskeleton toward the basal end (Hu, 2008). Cytokinesis is completed 
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by disassembly of the mother’s cytoskeleton and recruitment of the plasma 
membrane mediated by Rab11a (Agop-Nersesian et al., 2009). 
 
Controls of cell cycle progression in Toxoplasma 
As in any other eukaryotic organism, the Toxoplasma cell cycle is controlled by 
cyclin/CDK complexes (Kvaal et al., 2002). Three CDK and five cyclin candidates 
have been identified through Toxoplasma genome mining (Khan et al., 2002) and 
yeast two-hybrid (YTH) approaches (Khan et al., 2002; Kvaal et al., 2002). The 
CDKs that have been found in Toxoplasma are CDC28, a Cdk-activating kinase 
(CAK) ortholog of Plasmodium PfCDK7 and another Plasmodium PfCDK7 
ortholog (Gubbels et al., 2008b). YTH screens with CDC28 identified TgCYC1, a 
member of the H family of cyclins with a usual repetitive N-terminal domain 
(Kvaal et al., 2002) and TgCYC2, an ortholog of the A/B family cyclins (Kvaal and 
White, unpublished results). TgCYC1 complementation experiments in yeast 
demonstrated its function in vivo, whereas the substitution of yeast G1 cyclin 
(CLN2) in these experiments demonstrated that TgCYC1 is more similar in 
function to the mammalian H cyclin (Kvaal et al., 2002). Based on genome-wide 
expression array analysis throughout the tachyzoite cell cycle, four additional 
putative cyclins were identified (Behnke et al., 2010). Overall the findings display 
a lack of specificity in cyclin/CDK pairings and indicate that in Toxoplasma the 
function and checkpoint roles of cyclins are divergent from and likely more elastic 
than in the well-studied higher eukaryote model organisms. 
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Upon completion of cell division, Toxoplasma displays a uniform haploid DNA 
content indicative that parasites have a normal G1 stage as part of the 
developmental progression (Radke and White, 1998; Radke et al., 2003). Also, 
long periods of arrest of sporozoites in oocysts and bradyzoites in tissue cysts, 
as well as in non-dividing extracellular tachyzoites, indicate the presence of a G0 
phase (Cornelissen et al., 1984; Radke and White, 1998). The presence of the 
G1 phase checkpoints is provided by usage of the putative G1 cyclin inhibitor, 
pyrrolidine dithiocarbamate (PDTC), (Moon et al., 2004), which upon application 
arrests asynchronously dividing parasites in the G1 phase (Conde de Felipe et 
al., 2008).  
 
Treatment of mammalian cells with mammalian inhibitors of DNA synthesis such 
as aphidicoline (Yoo et al., 2004) or DNA damaging agents such as hydroxyurea 
(Bianchi et al., 1986) result in a reversible arrest at the G1/S boundary. When 
actively dividing tachyzoites are exposed to these inhibitors, DNA synthesis is 
blocked but the parasites pass through the G1/S boundary, duplicate 
centrosomes and form mitotic spindles, and then fail to complete DNA 
replication, and ultimately die (Shaw et al., 2001). In higher eukaryotes, DNA 
damage is assessed prior to mitotic entry. Therefore, Toxoplasma’s DNA 
damage checkpoint might take place during mitosis, at which point the budding 
process has already begun (White et al., 2007b) (Fig. 1-4). Additional support for 
this model is provided by excess thymidine treatment of parasites overexpressing 
Herpes simplex thymidine kinase. This leads to an arrest at the G1/S boundary, 
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precluding centrosome duplication and daughter formation. These processes 
would not start if DNA replication is blocked independently at the G1/S boundary 
(White et al., 2005). Notably, the thymidine arrest is reversible, since upon 
thymidine release the parasites continue growth and stay synchronous for 
approximately two cell cycles. Taken together, the lack of a true G2 phase 
combined with the onset of parasite budding before DNA replication is completed 
explains the departure of Toxoplasma from the reversible effects seen with use 
of DNA polymerase inhibitors in higher eukaryotic organisms (Gubbels et al., 
2008a). 
 
Further evidence that cell cycle progression controls in Toxoplasma differ from 
those of higher eukaryotic model organisms is provided by mining the 
Toxoplasma genome. Although cyclins and CDKs were identified as described 
above, several strongly conserved controllers like Cdc25, Polo-like kinase, or 
Aurora kinases could not readily be identified in the genome (Gubbels et al., 
2008b). Additional evidence for the nature of mitotic controls in Toxoplasma is 
derived from studies of a temperature sensitive tachyzoite mitotic mutant (Radke 
et al., 2000). When this mutant is grown at the restrictive temperature, a bi-
phasic arrest in two nearly equal populations of 1N and 2N DNA content is 
observed. Moreover, the 2N parasites form incomplete daughter buds, but their 
nuclei have not divided. This confirms that daughter formation can initiate in the 
absence of nuclear division but that there are controls in place necessary for the 
completion of daughter budding in the absence of nuclear division (Radke et al., 
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2000; White et al., 2005). Treatment of tachyzoites with high doses of 
microtubule antagonists such as orazylin and colchicine resulted in a complete 
disruption of subpelicullar and spindle microtubules, whereas the nucleus grew in 
size and became multilobed, but then failed to divide (Morrissette and Sibley, 
2002a). These findings suggest that disruption of the intra-nuclear spindle 
uncouples budding and can lead to mitotic failure and re-initiation of DNA 
synthesis. As such it seems that mitotic checkpoints require an intact intra-
nuclear spindle (Gubbels et al., 2008a). 
 
Cell division rate as a virulence factor in Toxoplasma gondii 
Three different clonal lineages of Toxoplasma, which are genetically closely 
related but differ in virulence, have been identified in North America and Europe 
(Sibley and Boothroyd, 1992; Howe and Sibley, 1995; Ajzenberg et al., 2009). In 
mice, the Type I genotype is the most virulent, followed by Type II and III, 
respectively (Kaufman et al., 1958; Kaufman et al., 1959). It has been noted that 
parasite growth rate correlates with virulence and in general is a main factor in 
apicomplexan pathogenicity (Diffley et al., 1987). Specifically, in Toxoplasma it 
has been shown that the length of the G1 cell cycle phase is significantly 
shortened in Type I strains (Radke et al., 2001) pointing to a mechanism behind 
enhanced virulence. One gene that is responsible for greater multiplication rate 
and thus virulence is rhoptry protein 18 (ROP18) (Taylor et al., 2006).  When the 
Type I allele of ROP18 was stably expressed in an avirulent Type III strain, these 
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parasites displayed enhanced acute virulence and lowered the lethal infectious 
dose in mice compared to the parent Type III strain (Taylor et al., 2006).  
 
C1. Epigenetics in Toxoplasma gondii  
 
In eukaryotes, DNA is packaged into chromatin, which is constantly remodeled 
between a relaxed state termed euchromatin and more compact structure called  
heterochromatin (Li et al., 2007). Euchromatin is actively transcribed whereas 
heterochromatin is transcriptionally silent (Li et al., 2007). The dynamic transition 
between these two states is controlled through epigenetic mechanisms, e.g. DNA 
methylation, nucleosomal remodeling, and covalent, reversible modifications of 
histones (Goldberg et al., 2007; Kouzarides, 2007). A histone modification that is 
directly associated with euchromatin is lysine acetylation of histones by histone 
acetyl transferase (HAT) (Allfrey and Mirsky, 1964). Conversely, heterochromatin 
is deacetylatied on these lysine residues by histone deacetylase (HDAC) 
(Thiagalingam et al., 2003). In 2000, Strahl and Allis coined the term “histone 
code”, which predicts that diverse covalent modifications of histone tails are 
recognized by effector molecules, which in turn mediate distinct outcomes, such 
as turning on and off gene expression (Strahl and Allis, 2000).  
 
In Apicomplexa a large pool of chromatin remodeling proteins has been identified 
(Dixon et al., 2010). Therefore, it is likely that epigenetic principles governing 
chromatin remodeling in higher eukaryotes also apply to Toxoplasma. The first 
evidence of the epigenetic machinery in alveolates, of which Toxoplasma is a 
member, surfaced in 1996, when it was discovered that Tetrahymena’s HAT p55 
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is orthologous to the yeast transcriptional adaptor general control 
nonderepressible 5 protein (GCN5) (Brownell et al., 1996). The GCN5 ortholog is 
also present in Toxoplasma, and this HAT is capable of modulating gene 
expression (Hettmann and Soldati, 1999; Sullivan and Smith, 2000). In addition, 
other HATs such as the MYST family of HATs (Smith et al., 2005), a SRCAP 
member of the SWI/SNF ATP-dependent chromatin remodelers (Sullivan et al., 
2003), and another splice variant of GCN5, TgGCN5-B, (Bhatti et al., 2006) have 
been described. Also its functional counterparts, the HDAC, and histone arginine 
methyltransferase (PRMT) have been purified in Toxoplasma (Saksouk et al., 
2005). For example, TgHDAC3 removes acetyl group from H4K5, H4K8, and 
H4K12, whereas TgSIR2 deacetylates H3K56 (Bougdour et al., 2010). 
 
Direct evidence of functional histone acetylation in Toxoplasma was provided by 
CHIP-chip experiments. The Kim group has shown that acetylation of H3K9, and 
tri-methylation of H3K4 at promoters marks actively expressed genes (Gissot et 
al., 2007). Conversely, gene repression was associated with tri-methylation of 
H3K9 and H4K20 (Sautel et al., 2007). Furthermore, it has been noted that 
acetylation is present in promoters of bradyzoite-specific genes destined for 
expression, but not necessarily expressed, yet (Behnke et al., 2008).   
 
One important difference in Toxoplasma’s epigenetic control mechanism is the 
absence of cytosine methylation of the genome (Gissot et al., 2008), which is 
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usually present at repressed promoters. Taken together, it is apparent that 
Toxoplasma possesses conserved as well as distinct epigenetic mechanisms. 
. 
Epigenetics and stage conversion 
Saksouk and co-workers demonstrated that TgGCN5-A and TgHDAC3 work in 
concert to activate or repress bradyzoite stage specific genes, respectively 
(Saksouk et al., 2005), i.e., TgGCN5-A activity is associated with active and 
TgHDAC3 with inactive promoters (Saksouk et al., 2005). In addition, TgGCN5-A 
was shown to be a key player in stress-induced bradyzoite differentiation (Bhatti 
et al., 2006). Another interesting aspect of bradyzoite conversion is that the 
expression levels of histones TgH2AZ and TgH2AX increase in bradyzoites of 
Toxoplasma, which might be necessary to spread chromatin repression and thus 
induce the latent bradyzoite stage (Dalmasso et al., 2009).  
 
DEAD box helicases 
Another set of proteins increasingly being recognized as having importance as 
epigenetic regulators of gene expression are helicases. Two epigenetically 
relevant types have been recognized: DNA and RNA helicases, which all belong 
to the DEAD box protein family since they share a DEAD or DEAH or DEXH 
amino acid sequence motif (Tuteja and Tuteja, 2004). Besides the DEAD motif, 
this helicase family shares eight other short motifs in various combinations 
contained within a region of 200-700 amino acids called the core region (Tuteja 
and Tuteja, 2004), which is also observed in Toxoplasma helicases 
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(www.ToxoDB.org). The less conserved stretches of amino acids contained in 
the remainder of the protein give helicases their specific, individual functions 
(Tuteja, 2003). In general, the conserved motifs of DEAD box proteins are 
involved in nucleic acid binding, nucleotide binding and ATP-dependent 
unwinding of DNA and RNA (Hall and Matson, 1999). These reactions are 
usually accomplished in concert with other enzymes or proteins.  
 
Sequence comparisons of Toxoplasma proteins revealed that they share a high 
degree of homology with plant proteins, e.g., Arabidopsis thaliana and peas 
(Pisum sativum). As such, it can be assumed that Toxoplasma’s helicases would 
have similar functions since they share extensive homology with plants. 
Functional analyses of RNA helicases in plants revealed that RNA helicases are 
involved in modulation of RNA structure and thus influence RNA synthesis, 
splicing, transcription, translation initiation, editing, rRNA processing, ribosome 
assembly, nuclear mRNA export, and degradation (Luking et al., 1998). On the 
other hand, DNA helicase function in plants ranges from DNA recombination and 
replication, to translation initiation, rDNA transcription, early-stage pre-rRNA 
processing, DNA repair, and cell division/proliferation (Tuteja, 2003).  
 
The best studied DEAD box family RNA helicase is the eukaryotic initiation 
factor-4A (eIF-4A), which is a homolog of PDH45, a member of the DEAD box 
family of DNA helicases in peas (Pham et al., 2000) and At3g19760, the DEAD 
box family of RNA helicase in Arabidopsis. The initial analysis of eIF-4A 
 22 
function/s demonstrated that it is involved in unwinding and translation initiation 
of mRNAs (Pause et al., 1994). However, the pea eIF-4A homolog, PDH45, was 
shown to have RNA helicase activity linked to protein synthesis (Pham et al., 
2000). Furthermore, PDH45 was shown to physically interact with and stimulate 
activity of topoisomerase I (Pham et al., 2000), which is involved in DNA-related 
processes such as replication, transcription and recombination (Wang et al., 
1990). These findings suggest that the DEAD box family helicases, whether they 
are DNA or RNA helicases, can have dual functions that affect RNA and DNA 
synthesis, processing and expression (Pham et al., 2000). 
 
Transcription factors in Toxoplasma 
An important aspect of gene expression is control of transcription. In eukaryotes 
including Toxoplasma, histone-modifying enzymes lack DNA binding domains, 
implying that they exist in complexes which are recruited by DNA-bound 
transcription factors (TFs) (Dixon et al., 2010). In general, promoter activity 
depends on an A/T-rich stretch termed the TATA box located 25-30 bp upstream 
of the transcription initiation site (Grosschedl and Birnstiel, 1980; Wasylyk et al., 
1980; Hu and Manley, 1981). The TATA box recruits the TATA-binding protein 
(TBP) (Kim et al., 1993a). The TBP together with TBP-associated factors (TAFs) 
are part of a large multiprotein complex called TFIID, which nucleates the 
formation of a pre-initiation complex, recruiting RNA polymerase II and other 
TFIIs enabling the onset of transcription (Van Dyke et al., 1988; Buratowski et al., 
1989; Kelleher et al., 1990).  
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Surprisingly, orthologs of the conventional TFs are absent from the Toxoplasma 
genome, making it hard to determine how these epigenetic modifiers are 
recruited to the target DNA (Dixon et al., 2010). This conundrum is even more 
puzzling as TBP is present in Toxoplasma, but the TATA box is generally missing 
from promoters (Meissner and Soldati, 2005). However, even higher eukaryotes 
contain many TATA-less promoters but contain so-called Initiator (Inr) elements 
sufficient for RNA polymerase II transcription initiation (Smale, 1997). It has not 
been determined whether a comparable Inr system is present in Toxoplasma. 
 
Evidence of specific TFs in Toxoplasma initially was derived from an in silico 
study of TFs. Aravind and co-work showed presence of Apetala2 (AP2) integrase 
DNA binding domains (Balaji et al., 2005), which act as TFs with major roles in 
developmental transitions and the stress response in plants (Jofuku et al., 1994). 
Additional evidence for presence of AP2-like TFs in Toxoplasma came from 
purification of TgHDAC3, which was shown to bind the apicomplexan AP2, 
TgCRC350 (Saksouk et al., 2005). Furthermore, Toxoplasma AP2 proteins were 
shown to co-purify with TgGCN5-B (Sullivan and Hakimi, unpublished results).  
 
The above data suggest that AP2 domain-containing proteins are one set of TFs 
that interact with epigenetic factors to control parasite gene expression (Dixon et 
al., 2010). To date, 68 proteins with the AP2 domain have been identified in 
Toxoplasma, compared to 27 in Plasmodium and 17 in Cryptosporidium (Iyer et 
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al., 2008). Sequence comparisons among AP2 domain-containing proteins in 
apicomplexans have demonstrated that this group of proteins is very diverse in 
size and composition (Dixon et al., 2010), indicating the possibility that a large 
number of genes might be regulated by these proteins. Moreover, recently White 
and Behnke have demonstrated that 24 of AP2 TFs display cyclic expression 
profiles distributed throughout the tachyzoite cell cycle (Behnke et al., 2010). In 
addition, a set of five AP2 TFs that were GFP-tagged demonstrated exclusive 
nuclear localization, as well as restricted cell cycle expression, as predicted by 
their respective mRNA accumulation patterns (Behnke et al., 2010). Taken 
together the plant-related AP2 family of transcription factors in Toxoplasma and 
other Apicomplexa has now provided a large set of transcription factors that  
differ from those of most model eukaryotes, suggesting a potentially distinct gene 
expression control mechanism at the transcriptional level. 
 
D1. Concluding remarks and major questions in the field today 
Toxoplasma gondii infects up to one-third of the world’s population and can 
cause life-threatening disease in certain risk groups. Furthermore, current drugs 
can cause severe side-effects and only eliminate the acute tachyzoite stage of 
toxoplasmosis, whereas the chronic bradyzoite stage is left unaffected. To 
reduce the impact of this disease on mankind and develop more effective 
treatment options, basic and applied research of the parasite’s biology is 
required. In general the most specific drug targets are found in those processes 
wherein the pathogen differs from the host.  
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The life cycle of Toxoplasma gondii in the intermediate host involves 
differentiation between developmental stages, which could be used as targets for 
development of more effective drugs. Likewise, the observation that the length of 
the G1 stage is a virulence factor, together with differences in control of cell cycle 
progression, can be exploited to combat this parasite. Advances in genetic, 
molecular, and bioinformatic tools enable scientists to better dissect and 
understand the pathways that govern these distinct processes in Toxoplasma. 
The central aim of this thesis was to identify and characterize the gene that is 
responsible for a G1 division arrest in a temperature sensitive (ts) mutant named 
FV-P6. 
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Figure 1-1. The life cycle of Toxoplasma gondii 
(A) Cats are the definitive host of Toxoplasma gondii, which upon ingestion of 
bradyzoites infected tissues enable the parasite to undergo sexual reproduction 
within feline entero-epithelia. Bradyzoites differentiate into merozoites, which 
replicate several times in the gut before differentiation into micro- and 
macrogametes, which upon fertilization develop into oocysts. Oocysts passed in 
feline feces undergo sporulation upon exposure to the ambient environment. 
Ingestion of tissue cysts or sporulated oocysts by intermediate hosts, which can 
be any warm-blooded animal, including humans, releases bradyzoites or 
sporozoites in the host intestine. The released parasites subsequently invade the 
intestinal epithelia and differentiate into tachyzoites marking the onset of asexual 
reproduction. Tachyzoites can be transmitted to fetuses and cause neurological 
defects and even spontaneous abortions. (B) The lytic cycle of actively dividing 
tachyzoites, which divide rapidly causes the massive tissue damage associated 
with clinical toxoplasmosis. 
Figure A  has been adopted from (Chiodini et al., 2001) and B is courtesy of Dr. 
Marc-Jan Gubbels, Boston College. 
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Figure 1-1. The life cycle of Toxoplasma gondii 
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Figure 1-2. Schematic representation of the somatic cell cycle in mammals 
A typical cell cycle consists of four sequential phases, namely G1, S, G2, and M. 
The figure was adopted from (van den Heuvel, 2005). 
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Figure 1-2. Schematic representation of the somatic cell cycle in mammals 
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Figure 1-3. Cell division cycle of Toxoplasma gondii tachyzoites 
(A) The G1 phase is the longest phase of the tachyzoite cell cycle and takes 
about 60% of the total cell cycle time of to complete. The S phase encompasses 
about 30% of the total time whereas mitosis/cytokinesis takes up 10%. 
(B) Schematic representation of endodyogeny. In G1 phase a mature tachyzoite 
is preparing to undergo endodyogeny. S phase involves DNA synthesis and 
initiation of daughter scaffolds. The M/C phase is characterized by internal 
budding of the two daughters within the mother parasite and completion of 
division by endodyogeny.  
Figure A is modified from (Radke et al., 2001) and B is modified from (Gubbels et 
al., 2006). 
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Figure 1-3. Cell division cycle of Toxoplasma gondii tachyzoites 
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Figure 1-4. Order and timing of organelle duplication in the tachyzoite cell 
cycle 
The major events of organelle duplication in the tachyzoite cell cycle. The 
organelle duplication can be used for tracing cell cycle progression in 
Toxoplasma. The cytoplasmic to cortical transition of IMC7 and IMC14 indicate 
progression through one third and first half of G1, respectively. The duplication of 
centrioles indicate onset of S phase. The presence of daughter buds indicates 
entry into M/C phase. The figure with modifications was adopted from (White et 
al., 2007a). 
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Figure 1-4. Order and timing of organelle duplication in the tachyzoite cell 
cycle 
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CHAPTER II 
PHENOTYPIC ANALYSIS OF TEMPERATURE SENSITIVE DIVISION 
MUTANT FV-P6 IDENTIFIES AN ARREST IN THE G1 PHASE OF THE CELL 
CYCLE 
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A2. Introduction  
Toxoplasma gondii is the causative agent of toxoplasmosis affecting about 30% 
of human population world wide (Montoya and Liesenfeld, 2004). Toxoplasma’s 
pathogenesis is the result of uncontrolled expansion of parasite biomass that 
results in tissue damage of the host. Parasite invasion, replication, and lysis 
enable spread of the infection through the host’s body. If the acute infection is not 
resolved by the host’s immune system then toxoplasmosis can cause death. The 
cause of the disease is fast lytic replication cycles lysing cells of the host.   
 
Of the three clonal lineages of Toxoplasma Type I is the most pathogenic in mice 
due to its faster growth rates (Sibley and Boothroyd, 1992). Faster growth is 
characterized by a shortened G1 phase of the cell cycle in Type I strains (Radke 
et al., 2001), therefore the length of the G1 phase is considered a virulence 
factor. 
 
This strong connection between the parasite’s virulence and cell division made it 
prudent to identify the genes involved in cell division and cell cycle progression. 
Initial research of Toxoplasma division indicated that certain aspects of its 
division vary from mammalian cells cycle where, for example, the onset of 
mitosis/cytokinesis occurs prior to completion of DNA synthesis (Radke et al., 
2001; Shaw et al., 2001). In order to elucidate the factors responsible for cell 
cycle control and progression a forward genetic approach has been put in place. 
Such approach proved to be successful to identify cell cycle control genes in 
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yeast (Nurse, 2001). This approach involves chemical mutagenesis of 
Toxoplasma, identification of mutants with growth defects, complementation of 
mutants with a wild type cosmid library and thus restoration of a wild type 
phenotype, and identification of a mutated gene through a plasmid rescue. One 
of these mutants is FV-P6.  
 
In this chapter the phenotypic analyses of this mutant are reported by combining 
DNA content analysis with cell biological assays to define the timing of the arrest 
in the cell cycle. We find that mutant FV-P6 arrests reversibly in G1 both 
immediately upon invasion (coming out of G0) and from any other stage of the 
cell cycle. 
 
B2. Results 
1. FV-P6 displays a growth arrest 
A forward genetic approach (Fig. 2-1) was utilized to generate a pool of 
temperature sensitive growth mutants in order to elucidate genes that are 
essential for cell cycle division and progression (Gubbels et al., 2008a). 
Temperature sensitive (ts) mutants were made by inducing point mutations with 
N-ethyl-N-nitrosourea (ENU) in the parent line, 2F-1-YFP2, which expressed 
cytoplasmic YFP, and resulting mutants were screened for growth at 35°C 
(permissive) or no growth at 40°C (restrictive) temperatures by recording the YFP 
fluorescence increase as a measure for growth (Fig. 2-2). Mutant FV-P6 was 
identified by this method. 
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Stability of the mutant phenotype is an important consideration for downstream 
analysis, i.e. if the mutant is prone to reversion back to a wild-type phenotype at 
the restrictive temperature it could interfere with detailed analysis and mutation 
mapping. To assess the stability of FV-P6 plaque assays with a high inoculum 
were set up at 40°C. The absence of plaques at 40°C (Fig. 2-3 C, D) showed that 
FV-P6 has a reversion frequency of less than 1 in 107, which is considered a 
stable phenotype. Moreover, when FV-P6 was incubated initially for 16 hrs at 
40°C and then shifted back to 35°C, plaque number and size were comparable to 
the controls kept exclusively at 35°C (Fig. 2-4). To corroborate FV-P6’s growth 
arrest, I recorded detailed growth kinetics of FV-P6 at 35°C, 37°C, and 40°C in 
384-well plates using increase of YFP fluorescence as read out. This showed 
that FV-P6 grows normally at 35°C and 37°C whereas no growth could be 
detected at 40°C (Fig. 2-5).  
 
2. FV-P6 arrests in the G1 phase of the cell cycle 
Knowing that FV-P6 has a ts growth defect, the next step was to determine at 
which phase of the cell cycle the arrest occurs. To this end we monitored 
changes in DNA content upon phenotype induction using flow cytometry. Two 
time points, 16 and 36 hrs, at both the permissive (35°C) and restrictive (40°C) 
temperatures were studied. The results showed that FV-P6 arrests 
predominately with a 1N nuclear content, reflecting the G1 phase of the cell cycle 
(Fig. 2-6 B). This arrest is already visible after 16 hrs of phenotype induction. 
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After 36 hrs, FV-P6 had a nuclear content of less than 1N, which likely indicates 
that the parasites started to disintegrate (Fig. 2-6 B).  
 
To corroborate and extend on the DNA contents findings, I used a set of cell-
biological markers to determine the stage of parasite development in the division 
cycle. A marker for the centrosome was used to monitor centrosome duplication 
in the parasite. Markers for α-tubulin and IMC3 were used to highlight the 
parasite’s mature and developing cytoskeletons as well as the mitotic spindle 
(Swedlow et al., 2002; Gubbels et al., 2004). In addition, MORN1 was used as a 
marker for the parasite’s cytoskeletal scaffold formation during cell division as 
well as a marker of the basal complex of Toxoplasma (Gubbels et al., 2006). 
Mutant FV-P6 along with the wild type strain were grown at 40°C for 16 and 36 
hrs and subjected to immunofluorescence assays (IFAs). Mutant FV-P6 
demonstrated arrest at the single cell stage as early as 16 hrs at 40°C, which 
persisted at 36 hrs (Fig. 2-7 C and D and Fig. 2-8 C and D). Moreover, FV-P6 
mutant did not duplicate its centrosome, which indicated that S phase entry did 
not occur. Consistent with this finding, no evidence for daughter budding was 
identified using the cytoskeletal marker IMC3 (Fig. 2-7 C and D). The 
cytoskeleton markers together with MORN1 indicated that the cytoskeleton of the 
arrested parasites is intact and the parasites do not display any obvious 
morphological signs of degradation (Fig. 2-8 C and D).  
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To investigate whether FV-P6’s arrest is uniform, I quantified the incidence of 
various cell cycle stages using antibodies against centrin and IMC3. Three 
different developmental stages were defined by presence of single centrosome, 
duplicated centrosomes, and budding parasites, which represent cell cycle 
phases of G1, S, and M/C, respectively. At 35°C the above cellular markers were 
distributed as follows: 27% single centrosome, 45% duplicated centrosome, and 
28% (Fig. 2-9). At 40°C 98% of the parasites contained only one centrosome, 
indicative of G1 phase. Although, 2% of parasites duplicated their centrosomes, 
none were able to progress into S/M phase (Fig. 2-9). Taken together, the IFA 
data are consistent with the DNA content analysis and indicate FV-P6 arrests 
quickly and tightly in the G1 stage of the cell cycle. 
 
3. FV-P6 arrests between one third and midway of G1 phase 
Recently, our lab identified and characterized a series of intermediate filament 
like (IMC) proteins which allow differentiation of the developmental stages at 
unprecedented spatiotemporal resolution (Anderson-White et al., 2010).  
Interestingly, three IMC proteins, IMC7, 12 and 14 change localization within the 
G1 stage of the cell cycle: IMC14 transition from the cytoplasm to the cortical 
cytoskeleton in the first 1/3 of G1 whereas IMC7 and IMC12 make this transition 
halfway through G1. Therefore these are ideal markers to determine at which 
part of G1 mutant FV-P6 arrests. Hence mutant FV-P6 was transiently 
transfected with plasmids expressing red fluorescent protein (CherryRFP) tagged 
to IMC7 and IMC14 proteins. As shown in Figure 2-10 A and B, at 35°C both 
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IMC7 and IMC14 display about an equal distribution between cortical and 
cytoplasmic localization. However, at 40°C IMC14 predominantly localizes to the 
cortex whereas IMC7 was mostly cytoplasmic. These results indicate that FV-P6 
arrests between the first one third and the halfway point of G1. 
 
The results presented in Figure 2-10 A and B are derived from parasites that 
were placed immediately at 40°C after inoculation of the host cells. In these 
experiments we observed that the parasites did invade, but not go through a 
single round of cell division (IFAs not shown). Since these parasites come out of 
a G0 cell cycle stage, from these results it is unclear whether parasites coming 
out of cytokinesis would arrest at the exact same stage. Therefore, an additional 
set of experiments was performed wherein the parasites were first allowed to 
replicate for 16 hrs at 35°C, and then placed for 16 hrs at 40°C. These parasites 
coming out of cytokinesis also arrested between the first one third and the 
halfway point of G1 (Fig. 2-10 E and F). As such, the arrest in early G1 is 
universal for FV-P6 parasites coming either out of G0 or coming out of 
cytokinesis. 
 
C2. Discussion 
In this chapter, I have shown that mutant FV-P6 arrests with a 1N DNA content  
after the first one third and before the first half of the G1 stage of the cell cycle 
(Fig. 2-6 B and 2-10). This arrest occurs within the first cell cycle following 
transition to the permissive temperature, both for parasites directly after invasion 
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(no division occurs at all) as well as for parasites coming out of cell division. 
These assessments are made both on the basis of DNA content analysis (Fig. 2-
6) and cell biological analysis using different cell cycle markers. For random 
cycling parasites at the permissive temperature the cell cycle stage distribution 
percentages using either DNA content analysis (60% G1 and 30% S) are 
different from the cell biological analysis (27% and 45%). This discrepancy is due 
to the nature of cell biological markers: centrosome duplication occurs already at 
the end of G1 phase and therefore a portion of the parasites with duplicated 
centrosomes are technically falsely classified as S-phase parasites. Similarly, 
cytokinesis is assigned by the presence of daughter cytoskeleton buds, which 
already initiates before completion of DNA replication. Regardless of this 
discrepancy under permissive condition, when the phenotype is induced at 40°C 
both assays agree on nearly all parasites arrested in G1: 98% using the cell 
biological markers (Fig. 2-9) and a uniform 1N population by DNA content 
analysis (Fig 2-6). Using the cell biological markers no gross structural or 
morphological defects were observed in the arrested parasites although after 36 
hrs of induction a DNA loss was detected by DNA content analysis (Fig. 2-6).  
 
When parasites have first been allowed to replicate at 35°C prior to being moved 
to 40°C the G1 arrest is visible within 16 hrs. Since a cell cycle is typically 6-8 hrs 
long, this occurs within two cell cycles. Moreover, when parasites invade at 40°C 
no cell division is observed at all suggesting the arrest occurs before entering the 
cell cycle. Taken together, the arrest in G1 is immediate and firm. It is noteworthy 
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that cycling parasites arrested for 16 hrs at 40°C are fully able to re-enter the cell 
cycle upon being moved to 35°C they can divide and grow, making the arrest 
fully reversible (Fig. 2-4). 
 
Compared to 16 different ts mutants displaying a G1 arrest that have been 
characterized to date, only two other mutants (12.5%) also display a reversible 
phenotype (Gubbels et al., 2008a). The genes responsible for the G1 arrest in 
these two mutants have not been elucidated. In addition, a reversible G1 arrest 
can be induced upon treatment with a the antioxidant and metal chelating 
compound pyrrolidine dithiocarbamate (PDTC), which arrests 85% of RH 
tachyzoites with 1N nuclear content and a single centrosome (Conde de Felipe et 
al., 2008). In smooth muscle cells the PDTC induced G1 arrest has been related 
to a mechanism involving the down regulation of cyclin/CDK activities and an 
increased expression of the CDK inhibitor p21 (Conde de Felipe et al., 2008). 
Whether the arrest in Toxoplasma is based on the same mechanism has not 
been validated. Although no cell cycle checkpoints have been elucidated in vivo 
in Toxoplasma a few potential cyclins and CDKs have been identified in the 
genome (Kvaal et al., 2002; Eaton et al., 2006; Gubbels et al., 2008b)  (Kvaal 
and White, unpublished results). It is however tempting to speculate that the 
reversible G1 mutants and the PDTC arrest function in cell cycle progression 
through an effect on the cell cycle regulators, which is visible when such mutants 
are moved back to permissive temperature or PDTC is washed away from wild 
type parasites, respectively, enabling parasites to resume cell cycle progression. 
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Figure 2-1. Schematic outline of forward genetic approach in Toxoplasma 
gondii 
Wild type parasites were mutagenized with ENU and screened for the desired 
temperature sensitive (ts) phenotype at the restrictive temperature (40°C). 
Mutated genes are identified by genetic complementation using wild type DNA 
libraries. Successful complementation is selected for by growth restoration of the 
ts mutant at 40°C.  
Figure is courtesy of Dr. Boris Striepen, University of Georgia. 
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Figure 2-1. Schematic outline of forward genetic approach in Toxoplasma 
gondii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Forward Genetic Approach  
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Figure 2-2. Scheme representing ts mutant generation and screening  
The 2F-1-YFP2 parent strain, which expresses a cytoplasmic tandem YFP 
protein (YFP-YFP) as a fluorescent reporter for growth, was mutagenized with 
ENU and the mutagenized population directly cloned in 384-well plates. 
Parasites were grown and subsequently the plates were duplicated. The plates 
were scored for growth at the permissive temperature (35°C) and restrictive 
(40°C) temperatures by measuring the YFP-YFP fluorescence using a 
fluorescence plate reader. Identified ts mutants were propagated for subsequent 
analysis. 
Figure is courtesy of Dr. Marc-Jan Gubbels, Boston College. 
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Figure 2-2. Scheme representing ts mutant generation and screening 
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Figure 2-3. The FV-P6 phenotype is stable  
T175 flasks grown to confluence with HFF cells were inoculated with (A) 102 or 
(B) 103 wild type parasites or with (C) 106 or (D) 107 FV-P6 mutant parasites to 
examine the reversion rate at 40°C. After 7-9 days of growth, plaques were 
stained. Examples of  white plaques are marked by red arrowheads.  
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Figure 2-3. The FV-P6 phenotype is stable 
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Figure 2-4. FV-P6’s arrest at 40°C is reversible 
Wild type and FV-P6 mutant parasites were incubated at 35°C and 40°C for 7 
days in T25 flasks seeded with HFF cells and subsequently stained for plaques. 
FV-P6 mutant’s arrest is reversible as the mutant’s growth was restored when it 
was moved from 16 hrs incubation at 40°C to 35°C for a period of 7 days. FV-P6 
mutant continuously grown at 40°C did not show any growth. The experiment 
was performed twice; error bars denote standard deviation. 
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Figure 2-4. FV-P6’s arrest at 40°C is reversible  
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Figure 2-5. FV-P6 arrests at 40°C 
Growth kinetics of (A) 2F-1-YFP2 parent strain and (B) mutant FV-P6 at 35°C 
(green), 37°C (blue), and 40°C (red) were generated by measuring fluorescence 
over a period of 7 days on a fluorescence plate reader. Parasites were grown in 
384 well plates. Averaged data from 4 independent wells are shown; error bars 
denote standard deviation. 
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Figure 2-5. FV-P6 arrests at 40°C 
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Figure 2-6. Distribution of FV-P6’s genomic DNA content at permissive and 
restrictive temperatures 
FV-P6 was grown at (A) 35°C and (B) 40°C for 16 and 36 hrs prior to harvest and 
ethanol fixation. The DNA was stained with SYTOX Green and the signal 
measured with a FACS calibur (BD). The red dashed lines refer to 1N and 1.8N 
DNA contents.  
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Figure 2-6. Distribution of FV-P6’s genomic DNA content at permissive and 
restrictive temperatures 
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 Figure 2-7. Cell biological assessment of FV-P6’s IMC and centrosome 
development with anti-Centrin and anti-IMC3 antibodies, respectively 
At 16 and 32 hrs post infection the wild type parent and mutant FV-P6 were 
methanol fixed and co-stained with anti-Centrin (red) and anti-IMC3 (green) 
antibodies, and DAPI (blue) to assess developmental progression. (A and B) The 
wild type showed a normal developmental progression evident by centriole 
duplication (red) and increase in parasite number (green). (C and D) FV-P6 
arrested at single stage parasites but its cytoskeleton stayed intact.  
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Figure 2-7. Cell biological assessment of FV-P6’s IMC and centrosome 
development with anti-Centrin and anti-IMC3 antibodies, respectively  
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Figure 2-8. Assessment of FV-P6’s development at 40°C with anti-MORN1 
and anti-α-Tubulin antibodies 
At 16 and 32 hrs post infection the wild type parent strain and FV-P6 were fixed  
with methanol and co-stained with anti-α-Tubulin (red) and anti-MORN1 (green) 
antibodies, and DAPI (blue) to assess developmental progression. (A and B) The 
wild type strain showed a normal developmental progression evident by increase 
in parasite number. (C and D) FV-P6 arrested at single stage parasite with 
preserved subpellicular microtubules (red) and MORN1 (green) depicting an 
intact cytoskeleton. 
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Figure 2-8. Assessment of FV-P6’s phenotype at 40°C with anti-MORN1 and 
anti-α-Tubulin 
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Figure 2-9. FV-P6 arrests uniformly at the single centrosome at 40°C  
FV-P6 mutants were grown at 35°C and 40°C for 16 hrs post-infection followed 
by methanol fixation and immunofluorescence assay with anti-Centrin (red), anti-
IMC3 (green) antibodies, and DAPI (blue). One hundred random vacuoles at 
each temperature were counted and scored for single or duplicated centrosomes 
and budding parasites representative of different stages of parasite’s 
development; C1, C2, and C2/B refer to tachyzoites containing a single 
centrosome, doubled centrosomes, and doubled centrosomes in tachyzoites 
undergoing budding, respectively. 
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Figure 2-9. FV-P6 arrests uniformly in the G1 phase of the cell cycle 
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Figure 2-10. FV-P6 arrests between the first one third and half of G1 phase 
FV-P6 mutant was transiently transfected with (A) CherryRFP-IMC14 or (B) 
CherryRFP-IMC7 expressing plasmids and initially incubated at 35°C for 16 hrs 
prior to 16 hrs incubation at 35°C and 40°C. As in (A and B), FV-P6 mutant was 
transfected with (E) Cherry-IMC14 and (F) Cherry-IMC7 expressing plasmids and 
directly incubated at 35°C and 40°C for 16 hrs. Parasites were methanol fixed 
and the immunofluorescence assay performed using Cherry antiserum. 
Fluorescence localization was scored for cytoplasmic or cortical localization for 
Cherry-IMC14 (C) or Cherry-IMC7 (D) at both temperatures. Averages from 100 
vacuoles counted at each timepoint in two independent experiments are shown; 
error bars denote standard deviation. 
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Figure 2-10. FV-P6 arrests between the first one third and half of G1 phase 
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CHAPTER III 
A POINT MUTATION IN CACTIN IS RESPONSIBLE FOR THE 
TEMPERATURE SENSITIVE G1 ARREST IN TOXOPLASMA GONDII 
MUTANT FV-P6 
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A3. Introduction 
In chapter II the generation of ts growth mutant of Toxoplasma gondii was 
described and the growth arrest for FV-P6 at G1 phase at 40°C was elucidated. 
The next question that needed to be addressed is what is the gene responsible 
for the temperature sensitive growth arrest. In order to identify the gene and the 
mutation, I used a genetic complementation approach.  
 
Although the process of making ts mutants has been very successful, 
identification of mutated genes has been challenging in the Toxoplasma system 
since genetic crosses are unpractical; sexual recombination can only be 
performed by cat infections, which occur in low efficiency. Moreover, the RH 
laboratory parasite strain lost the ability to infect cats and in addition, the 
temperature sensitive mutants are unlikely to survive the body temperature of the 
cat. Therefore, several genetic complementation strategies based on the 
transfection of wild type DNA libraries have been explored to elucidate genes 
underlying the mutant phenotypes. Among these strategies was an episomal 
vector-based system, which would maintain stable episomes in Toxoplasma 
allowing rescue and subsequent bacterial transformation (Black and Boothroyd, 
1998). Unfortunately, analysis of recovered plasmids demonstrated that 
recombination of the plasmids occurred resulting in decreased stability which 
limited the usefulness of this approach (Black and Boothroyd, 1998). A second 
complementation approach used a cDNA library cloned in the Gateway in vitro 
system (Hartley et al., 2000). In this approach genomically integrated library 
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plasmid fragments could be recovered in bacteria using in vitro recombination of 
the recovered total genomic DNA. However, this library was largely unsuccessful 
in complementing ts mutants and only one ts mutant was complemented with this 
library ((White et al., 2007a) and Gubbels, White, Striepen, unpublished data). 
Such low complementation efficiency can be explained by the length constraints 
of a plasmid based library. Moreover, the representation of cDNA libraries is 
highly skewed toward abundant transcripts. To overcome the problem of under-
representation and short inserts, a genomic cosmid library in the ToxoSuperCos 
backbone was constructed with an average insert size of around 40 kb. This 
library has a 900-fold genomic coverage. Since cosmids also integrate randomly 
in the genome, identification of library inserts was based on plasmid rescue in E. 
coli (Gubbels et al., 2008a).  
 
In this chapter, I describe the successful complementation of mutant FV-P6 with 
the wild type genomic cosmid library. FV-P6 transfectants with the cosmid library 
were selected for growth restoration at 40°C and 4 out 4 (100%) library 
transfections successfully restored growth. Mutant FV-P6 was one of the first 
mutants to be complemented with this method. By rescuing a piece of the library 
fragment back in bacteria I was able to determine that the complementing gene 
was a Cactin ortholog. Moreover, I showed that this gene contains the 
temperature sensitive mutation resulting in an amino acid change from tyrosine 
to histidine in the encoded protein. 
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B3. Results 
1. Cosmid library complementation of FV-P6 restores wild type growth 
Four independent transfections of FV-P6 mutant with the ToxoSuperCos cosmid 
library (Fig. 3-1 A) were performed, which resulted in growth restoration in all 4 
cases 16 days post-transfection whereas no growth was observed in the no DNA 
transfection control. To ensure stable integration of the backbone of the 
complementing cosmid into the genome the flasks were passed multiple times 
under pyrimethamine selection, which is the resistance gene encoded in the 
cosmid backbone. Because episomal plasmids or cosmids are not stable in the 
Toxoplasma system, integration of the ToxoSuperCos backbone in the genome 
enables subsequent plasmid rescue to identify the complementing library 
fragment. 
 
In order to identify the complementing piece of the library, the library fragment  
from the complemented parasite had to be shuttled into bacteria. For this 
purpose the genomic DNA from complemented FV-P6 was isolated and digested 
with either BglII, HindIII, or XhoI. The cosmid backbone contains single restriction 
sites in  the multiple cloning site of the cosmid upstream of KanR gene (Fig. 3-1). 
In order to form a functional plasmid by self-ligation that can be recovered in E. 
coli, the restriction enzyme of choice must cut within the DNA insert of the 
cosmid such that the cosmid backbone needed for bacterial maintenance, the 
KanR gene and the origin of replication (ori), are contained in the rescued 
plasmid, together with the flank of the library insert. Self-ligated restriction digests 
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were electroporated into E. coli. Colonies formed for all 3 enzymes for all 4 
complementations, however, colony numbers differed dramatically between 
digests performed with different enzymes used for the rescue (results not 
shown). Diagnostic digests were performed on plasmid DNA isolated from 6 
colonies from each plate for all 4 independent complementations to identify 
rescue regions prior to sequencing (Fig. 3-2). The BglII/NotI digest should 
release the 2.1 kb backbone from all rescue plasmids. Since results were 
consistent for all the rescues, one representative plasmid per plasmid rescue 
was sequenced. 
 
BLASTN searches of the ToxoDB genome database with the obtained plasmid 
rescue sequences all mapped to chromosome VI within 2 kb from each other 
(Fig. 3-3). However, only one end of each large cosmid insert is mapped, 
therefore an up to 50 kb extension, representing the maximum cosmid insert 
length, was considered as the region containing the potential complementing 
sequence. As such, the smallest, overlapping region of the rescues identified a 
47 kb stretch containing 7 predicted genes (Table 3-1).  
 
2. Cosmid TOXOA93 spanning the mapped region on chromosome VI 
confers growth restoration  
To further scrutinize the validity of the plasmid rescues, I explored a collection of 
10,000 end-sequenced cosmid clones mapped to the genome to select 
overlapping cosmid clones spanning the identified region (Fig. 3-3). To reduce 
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the number of candidate genes within the originally mapped library rescue, two 
single cosmids were selected: TOXOA93 and TOXOD43, covering the first 4 and 
the last 3 predicted genes, respectively (Fig. 3-3). Upon complementation of FV-
P6 mutant with TOXOA93 and TOXOD43, only cosmid TOXOA93 was able to 
successfully restore wild type growth at 40°C (Fig. 3-4 E). As a result the number 
of candidate genes was narrowed down from 7 to 4.  
 
3. Phenotypic characterization of TOXOA93 complemented FV-P6 mutant 
To assess whether cosmid TOXOA93 restored growth of FV-P6 to wild type 
levels a growth assay was performed at three different temperatures. As shown 
in Figure 3-5 B, TOXOA93 indeed enabled FV-P6 to grow again at restrictive 
temperature with wild type kinetics. 
 
To investigate cell cycle progression and stability of TOXOA93 complemented 
FV-P6, IFAs were done with the cellular anti-Centrin and anti-IMC3 markers after 
16 hrs at 40°C (Fig. 3-5 C and D). The IFA assays (Fig. 3-5 C) demonstrated that 
complemented FV-P6 mutant was able to duplicate its centrosome, indicative of 
S-phase entry, and undergo budding, marked by IMC3, which demonstrated M/C 
onset. Complemented FV-P6 was able to increase in number by having 4 
tachyzoites per PV at 16 hrs (Fig. 3-5 D). These data suggest that G1 arrest of 
the FV-P6 phenotype was rescued. Furthermore, IFA assays with anti-α-Tubulin 
and anti-MORN1 on complemented FV-P6 showed that cytoskeletal components 
of the dividing parasites were intact as the parasite progressed through the cell 
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cycle (Fig. 3-5 D). Mainly, MORN1 still localized to the basal end and 
subpellicular microtubules radiated from the apical end to about two thirds of the 
parasite’s body plane (Fig. 3-5 D). 
 
4. A single point mutation in gene 49.m00063, a Cactin ortholog, is 
responsible for FV-P6’s G1 arrest 
To determine the single gene responsible for the phenotype, the four remaining 
candidate genes were PCR amplified from wild type genomic DNA with primers 
designed to amplify from 500 bp upstream of the transcriptional start site to 25 bp 
after the stop codon. All four candidate genes were successfully PCR amplified 
(Fig. 3-6 B), gel purified, and transfected individually in FV-P6 mutant. On day 14 
post-transfection, the wild type growth at 40°C was restored by the amplicon of 
gene 49.m00063, encoding an ortholog of Cactin (Fig. 3-6 E). Transfections with 
these four amplicons were repeated two more times with similar results. 
 
To confirm that the wild type allele but not the FV-P6 mutant Cactin allele is 
capable of restoring the wild type phenotype, the Cactin gene was amplified from 
both wild type and FV-P6 genomic DNA. Upon transfection into FV-P6 and after 
16 days of incubation at 40°C, growth restoration was observed in 
complementations with the wild type allele (Fig. 3-7 A) but not with the FV-P6 
mutant Cactin allele (Fig. 3-7 C). The plaque sizes of FV-P6 complemented with 
the PCR product were comparable in size to the plaques obtained with the 
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TOXOA93 cosmid, suggesting that only Cactin is sufficient and necessary for 
complementation of the FV-P6 mutant.  
 
The next step was to determine where the ENU induced point mutation is 
located. Hereto the wild type and FV-P6 mutant genomic DNA Cactin amplicon 
were PCR amplified, gel purified, and sequenced. This revealed a single point 
mutation from T to C in exon 9, which changed a codon at amino acid position 
661 from tyrosine to histidine (Fig. 3-7 E).  
 
Database search identified that Cactin is highly conserved across eukaryotes 
including the phylum of Apicomplexa (Fig. 3-8). Furthermore, the identified 
mutation lies in the highly conserved C-terminus region of Cactin (Lin et al., 
2000). Further sequence analysis showed that, TgCactin has a nuclear 
localization signal (NLS) encoded in the N-terminus, a low homology cyclin α-fold 
(Noble et al., 1997), and a highly conserved Cactin-mid region of unknown 
function (Fig. 3-9 A). The expression profile of Cactin mRNA throughout 
tachyzoite development displayed an even, low basal level of the transcript 
throughout tachyzoite development with a highest expression in the first half of 
G1 (Fig. 3-10). 
 
C3. Discussion 
The FV-P6 mutant was successfully complemented in 4 independent 
transfections with the wild type ToxoSuperCos cosmid library. Analysis of the 
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complementing library fragments revealed a 47 kb region on chromosome VI to 
contain the complementing capacity (Fig. 3-3). Seven potential candidate genes 
are encoded in this fragment (Table 3-1). To narrow down the number of genes 
in the complementing region, two cosmids were chosen for transfections: 
TOXOA93 and TOXOD43, covering 4 and 3 genes, respectively (Fig. 3-3). Only 
TOXOA93 cosmid was able to successfully restore wild type growth of FV-P6 at 
40°C (Fig. 3-4 E and 3-5 B). PCR amplification of the 4 single genes covered by 
TOXOA93 and subsequent transfection into FV-P6 resulted in wild type growth 
restoration only with 49.m00063, encoding a Cactin ortholog (Fig. 3-6 E). 
Moreover, IFA analysis demonstrated the G1 arrest was relieved and the 
complemented mutant progressed normally through cell division at the restrictive 
temperature (Fig. 3-5 C and D).  
 
Moreover, only Cactin amplified from the wild type genomic DNA and not from 
mutant FV-P6 was able to complement the phenotype (Fig. 3-7). This indicated 
that Cactin does not act as a suppressor and must contain the point mutation 
responsible for the phenotype. Subsequent sequencing of the wild type and 
mutant locus identified a single point mutation leading to a Tyr661His amino acid 
change (Fig. 3-7 E). Importantly, this amino acid is conserved across evolution 
and resides in a conserved region of the protein (Fig. 9 B and Fig. 3-8) (Lin et al., 
2000). A change of an aromatic Tyr residue into a positively charged His residue 
is a dramatic change, which is consistent with the loss of function. Whether the 
mutation leads to instantaneous misfolding of the protein upon incubation of the 
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parasites at 40°C or whether the protein misfolds upon translation at 40°C cannot 
be directly deduced. Some evidence is provided by the mRNA expression profile, 
which is relatively low and quite constitutive. The apparent 0.8 fold spike in the 
first half of G1 phase (Fig. 3-10) is in absolute terms very modest (Behnke et al., 
2010) although it did not escape our attention that the timing of the spike roughly 
coincides with the timing of FV-P6 arrest at 40°C (Chapter II). Based on the quick 
induction of the phenotype and the relatively flat mRNA expression levels I 
currently favor the scenario of instantaneous Cactin protein misfolding upon 
incubation of the parasites at 40°C. 
 
The point mutation found in the FV-P6 Cactin allele changes a Tyr into a His. 
Tyrosines can be phosphorylated, which are often key events in signal 
transduction mechanisms (van der Geer et al., 1994). Up to date no canonical 
tyrosine kinases have been identified in the Toxoplasma genome (Peixoto et al., 
2010) or the genome of the related Plasmodium parasite (Ward et al., 2004). 
However, recent data showed that a parasite encoded kinase exported into the 
host cell, TgROP16, is capable of directly phosphorylating a tyrosine residue on 
host protein STAT6 (Ong et al., 2010).  Such evidence opens the door to other 
non-canonical tyrosine kinases that could be active in the parasite. Whether Tyr 
661 in Cactin would be a site of phosphorylation requires further work, however, 
at 35°C the parasite harboring the mutant allele is fully functional and as such 
this data indicates phosphorylation would not be critical to the function of Cactin.  
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Cactin was first identified as part of the Rel pathway in Drosophila (Lin et al., 
2000). In general the Rel pathway is involved in morphogenesis, embryogenesis, 
and differentiation as well as innate immunity (Ghosh et al., 1998). However, 
many organisms, including C. elegans and T. gondii do not contain the Rel 
pathway, but do encode a Cactin ortholog in their genome (Pujol et al., 2001). 
These result therefore imply that Cactin must have other function besides a 
function in the Rel pathway. Whether Cactin moonlights with this other yet 
unknown function in organisms with a functional Rel pathway has not been 
determined. Features gleaned from the primary Cactin sequence are an N-
terminal NLS as well as a cyclin α-fold and a highly conserved domain in C-
terminus (Fig. 3-9A). Therefore I anticipate a nuclear localization of Cactin. Such 
localization could suggest a possible role in control of gene expression. Very 
recently it was shown that early in G1 the gene expression profile of tachyzoites 
changes dramatically (Behnke et al., 2010) and therefore such hypothesized 
function would be consistent with the FV-P6 phenotype. The cyclin α-fold 
consists of two compact domains each containing five alpha helices involved in 
protein recognition necessary for cell cycle and transcription control (Noble et al., 
1997). Presence of this fold in Cactin hints at its function as a potential 
transcription regulator since mutation in Cactin causes G1 arrest and prevents 
cell cycle progression. In addition, the point mutation is localized in the strongest 
conserved region of the protein. Although the function of this domain is not well 
defined the strong cross species conservation combined with the temperature 
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sensitive allele identified here strongly suggest this domain is of prime 
importance for function of Cactin. 
 
In summary, in this chapter it was determined that a point mutation in Cactin is 
responsible for the G1 growth arrest of the mutant. Furthermore, the point 
mutation is located in the highly conserved C-terminus, which caused tyrosine to 
histidine substitution likely resulting in misfolding and ablation of the Cactin’s 
function at the restrictive temperature. The function of Cactin in organisms 
without a Rel pathway, such as Toxoplasma, is currently unknown. 
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Figure 3-1. Map of the ToxoSuperCos backbone and nature of genomic 
integration 
(A) The ToxoSuperCos cosmid has double cos-sites derived from SuperCos 
(Stratagene, La Jolla, CA) combined with the KanR gene and the origin of 
replication from the pDONR201 plasmid (Invitrogen, Carlsband, CA), the 
pyrimethamine resistant gene of T. gondii, dihydrofolate reductase thymidylate 
synthase (DHFR-TSm2m3), and a multiple cloning site containing restriction sites 
BglII, HindIII, and XhoI, among others. The cosmid inserts were generated by 
isolating wild type genomic DNA from the RH strain, partial digestion with Sau3AI 
and ligation into the BamHI digested ToxoSuperCos backbone. (B) Transfection 
of the library into the parasites results in stable integration in the parasite’s 
genome. By selecting for pyrimethamine resistance, integration of the cosmid 
backbone is secured, which requires linearization of the cosmid at a random 
point. Multiple restriction sites to rescue the region required for bacterial 
maintenance, Kanamycin selectable marker (KanR) and (ori) can be used to 
obtain the flank of the library insert in a plasmid in bacteria.  
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Figure 3-1. The map of ToxoSuperCos backbone and nature of genomic 
integration 
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Figure 3-2. Restriction enzyme analysis of plasmids rescued from the 
complemented FV-P6 mutant.  
Genomic DNA was purified from cosmid library of complemented FV-P6 and 
single digested with BglII, HindIII, or XhoI. Digested DNA was purified and self-
ligated followed by electrophoration in DH12S E. coli. Bacteria were plated on 
LB-KAN plates and DNA was extracted from six colonies grown up per plate. 
Mini prep DNA was digested with BglII/NotI and run on a 1% agarose gel.  
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Figure 3-2. Restriction enzyme analysis of plasmids rescued from the 
complemented FV-P6 mutant 
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Figure 3-3. Chromosome VI, position 3,182,879 – 3,232,879, contains the 
sequence required to complement mutant FV-P6 
The analysis of sequences from the plasmid rescue revealed the identity of the 
genomic DNA library fragment in the FV-P6 complementing cosmid. Across the 4 
successful complementations, two independent sequences were recovered, 
likely representing two different cosmids from the library. Since complementing 
cosmids are only rescued from one side, the other end of the cosmid insert is 
unknown. The maximum cosmid insert length of 50 kb is assumed in the map. 
Between the two independently obtained sequences, the shared region 
encompasses about 47 kb of the chromosome VI, encoding 7 putative genes. 
End-sequenced and mapped cosmids labeled A-I are available as frozen stocks 
and can be used to fine map the region containing the gene responsible for 
complementation. Cosmids A (TOXOD43) and B (TOXOA93) were selected for  
fine mapping. 
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Figure 3-3. Chromosome VI, position 3,182,879 – 3,232,879, contains the 
sequence required to complement mutant FV-P6 
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 Figure 3-4. Cosmid TOXOA93 complements mutant FV-P6  
(A) Pulsed field gel electrophoresis of cosmid TOXOA93 digested with AvrII and 
cosmid TOXOD43 digested with NcoI. The expected band sizes for TOXO93 are 
3.9 kb, 7.1 kb, and 34.1 kb whereas for TOXOD43 the sizes are 2.1 kb, 5.4 kb, 
5.8 kb, 13.7 kb, and 22.6 kb. (B-E) Plaque assays of FV-P6 transfected with 
TOXOD43 grown at (B) 35°C (permissive) and (D) 40°C (restrictive) as well as of 
TOXOA93 grown at (C) permissive and (E) restrictive temperatures. Red arrow 
heads point at representative plaques. Note that TOXOA93 successfully 
complemented FV-P6 at 40°C (E) but TOXOD43 did not (D).  
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Figure 3-4. The TOXOA93 cosmid complements FV-P6 mutant 
 
 83 
Figure 3-5. Cosmid TOXOA93 restores FV-P6’s wild type phenotype at 40°C 
(A-B) Growth curves of (A) FV-P6 and (B) FV-P6 successfully complemented 
with cosmid TOXOA93 and grown at 35°C (green), 37°C (blue), and 40° (red). 
Growth was measured by the parasite’s increase in cytoplasmic YFP 
fluorescence over a period of 7 days. Note growth restoration of FV-P6 + 
TOXOA93 at 40°C (G, red line) versus no growth for FV-P6 (F, red line). The 
error bars denote standard deviation across 4 replicate wells. (C-D) At 16 hr post 
infection FV-P6 parasites complemented with TOXOA93 cosmid were methanol 
fixed and stained with (C) anti-Centrin (red) and anti-IMC3 (green) or (D) anti-α-
tubulin (red), anti-MORN1 (green) to assess the development and cytoskeleton. 
DAPI (blue) highlights DNA. (C-D) The complemented FV-P6 showed a normal 
cell cycle progression evident by centrosome duplication (red), the presence of 
daughter buds as well as by a general increase in parasite numbers per vacuole 
(green).  
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Figure 3-5. Cosmid TOXOA93 restores FV-P6’s wild type phenotype at 40°C 
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Figure 3-6. Growth of FV-P6 at 40°C is restored by gene 49.m00063 
(A) The region of interest on chromosome VI identified by cosmid library and 
single cosmid (TOXOA93) complementation encodes four genes as indicated. 
Red bars represent exons. (B) PCR products spanning the respective genes 
were amplified from wild type genomic DNA (1) 49.m00062, (2) 49.m03405, (3) 
49.m00063, (4) 49.m03404. (C-F) Plaque assays of FV-P6 transfected with the 
gene amplicons as indicated and selected for growth at the restrictive 
temperature. Only the 49.m00063 amplicon resulted in growth restoration of FV-
P6 as evident by presence of plaques (red arrow heads).   
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Figure 3-6. Growth of FV-P6 at 40°C is restored by gene 49.m00063 
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Figure 3-7. A single point mutation in exon 9 of 49.m00063 is responsible 
for the growth defect of FV-P6 at restrictive temperature 
(A-B) Plaque assay stains of FV-P6 transfected with (A) wt 49.m00063 PCR 
product, (B) TOXO93 cosmid, (C) FV-P6 49.m00063 PCR product, and (D) no 
DNA control. Flasks were incubated 7 days at 40°C. Note that FV-P6 transfected 
with (A) wt 49.m00063, but not (C) FV-P6 49m.00063, was able to restore FV-
P6’s growth (red arrow heads indicate representative plaques). (E) A single T 
(blue) to C (red) nucleotide change was identified resulting in a tyrosine 
(magenta) to a histidine (green) change in 49.m00063.  
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Figure 3-7 A single point mutation in exon 9 of 49.m00063 is responsible for 
the growth defect of FV-P6 at restrictive temperature 
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Figure 3-8. Phylogenetic relationship between Cactin family members 
Cladogram was constructed using the CLUSTAL W algorithm with distances 
calculated by the Neighbor-Joining method (Thompson et al., 1994). Cactin is 
highly conserved among apicomplexans (pink box). Numbers at nodes represent 
bootstrap values. 
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Figure 3-8. Phylogenetic relationship between Cactin family members  
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Figure 3-9. Pfam sequence analysis of TgCactin 
(A) Amino acid sequence of Cactin was analyzed for protein features. A nuclear 
localization signal (NLS), green box, was found in the N-terminus. The protein 
has a highly conserved C-terminus, blue box, within which in position 661 the 
mutation was identified (asterisk). Also, it has a low homology region to a cyclin 
α-fold, orange box, and a Cactin-mid conserved region, red box. (B) Alignment of 
the highly conserved C-terminus region of Cactin between amino acid 635 to 
694. In position 661 of TgCactin sequence a histidine to tyrosine substitution is 
marked in green H. 
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Figure 3-9. Pfam sequence analysis of TgCactin 
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Figure 3-10. Expression profile of TgCactin in tachyzoite development 
Affymetrix array expression pattern of the Cactin mRNA through tachyzoite 
development. Cell cycle stages are indicated on the x-axis. RH strain parasites 
expressing herpes simplex thymidine kinase (TK) were synchronized by a 
thymidine block. mRNA of synchronized parasites was collected at one hour 
intervals post thymidine block release. Progress through one cell cycle is shown; 
the background expression is about 0.8, the moderate expression is 1.2, and 
high expression is 1.8. 
Data courtesy of Dr. Michael White, University of South Florida. 
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Figure 3-10. Expression profile of TgCactin in tachyzoite development 
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Table 3-1. The genes covered by the region of the plasmid rescue of the FV-
P6 complemented by the cosmid library 
List of the genes located in the region of the plasmid rescue on chromosome VI. 
The genes are listed by their ToxoDB ID and gene name. 
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Table 3-1. The genes covered by the region of the plasmid rescue of the FV-
P6 complemented by the cosmid library 
 
GENE ID GENE NAME 
49.m03404 Conserved hypothetical protein 
49.m03405 Hypothetical protein 
49.m00063 Cactin 
49.m00062 Coatmer epsilon subunit 
49.m03407 Ubiquitin binding 
49.m03408 Conserved hypothetical 
49.m03409 16S pseudouridylate synthase 
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CHAPTER IV 
DISSECTION OF CACTIN’S FUNCTION; 
A POTENTIAL ROLE IN EPIGENETIC CONTROL OF GENE EXPRESSION 
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A4. Introduction 
1. Known functions of Cactin in eukaryotes 
As mentioned in chapter III, Cactin is highly conserved with a very strongly 
conserved C-terminal region of unknown function. Although Cactin was identified 
a decade ago (Lin et al., 2000) its role and function in eukaryotes are poorly 
understood. A few recent studies of Cactin in various eukaryotic systems have 
slowly started to unravel Cactin’s function, though many questions remain. 
 
Cactin was originally discovered in Drosophila through a yeast-two hybrid (YTH) 
screen with Cactus, the IκB homolog, which was used as bait (Lin et al., 2000). 
The name of Cactin was derived from the fact that this protein is a specific 
Cactus interactor (Lin et al., 2000). Both, Cactus and Cactin, in mammals, are 
part of the Rel pathway, which contains the NFκB transcription factor involved 
the innate as well as adaptive immunity (Ghosh et al., 1998; Vallabhapurapu and 
Karin, 2009). Very recently, human Cactin (hCactin) was identified as a nuclear 
factor that co-immunoprecipitated with I-kappa-BL (IκBL) (Atzei et al., 2010a), a 
nuclear member of the IκB family proteins, which inhibits activation of NFκB 
(Baeuerle and Henkel, 1994). Furthermore, hCactin was shown to be a repressor 
of Toll-like receptors (TLRs) and interferon regulator factors (IRFs) (Atzei et al., 
2010a), which facilitate immune responses in humans. On the other hand, in 
invertebrates, such as Drosophila the Rel pathway has been shown to act in 
morphogenesis, embryogenesis, and differentiation (Govind, 1999; Lin et al., 
2000). In addition, it has been shown that Cactin functions in early development 
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of zebrafish (Danio rerio). Knockdown of Cactin expression in the early embryos 
resulted in a bent body with shortened anterioposterior axis, more rounded head, 
and about 80% mortality (Atzei et al., 2010b). Furthermore, decreased eye size, 
and smaller distance between crown and mandibular arches in the oral cavity 
also suggested Cactin’s role in controlling neural development (Atzei et al., 
2010b). These findings suggested that Cactin has other functions besides 
immunity in metazoans.  
 
Although, early Drosophila work supports the function of Cactin in the Rel 
pathway, many lower eukaryotes and some plants lack the Rel pathway 
components yet do encode a strongly conserved Cactin protein. Examples of 
such organisms are C. elegans (Pujol et al., 2001), Toxoplasma gondii, and 
Arabidopsis thaliana. Presence of a Cactin homolog in these organisms without 
all the proteins of the Rel pathway imply that Cactin evolved earlier than the Rel 
pathway itself and that Cactin might have another, more universal function.  
 
In C. elegans Cactin is involved in distal tip cells (DTCs) migration at the end of 
larval morphogenesis (Tannoury et al., 2010). Furthermore, RNAi depletion 
showed that DTC pathfinding defects were similar to worms that had defects in 
Rac signaling (Lundquist et al., 2001). Rac proteins are small GTPases that 
regulate actin and microtubule cytoskeletal organization, orientation, and 
stabilization thus affecting cell migration and pathfinding (Hall, 2005). Tannoury 
and co-workers proposed that the mechanism of CACN-1 function is by negative 
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regulation of GTPase MIG-2 activity at the end of DTC migration (Tannoury et al., 
2010). Furthermore, in Arabidopsis thaliana, Cactin has been shown to have a 
potential role in a root development (Dr. Masson and Katherine Baldwin, 
University of Wisconsin at Madison, personal communication) causing lethality 
during early embryogenesis when deleted. 
 
In humans additional potential functions of Cactin have been identified in cancer, 
diabetes, obesity (Ewing et al., 2007) and autoimmune diseases (Lehner et al., 
2004). Here Cactin was identified through either immunoprecipitation combined 
with mass spectrometry analysis (Ewing et al., 2007) or by a yeast two-hybrid 
(YTH) screen (Lehner et al., 2004). In the first study Cactin co-
immunoprecipitated (co-IP) with RNA binding protein S1 (RNPS1) a protein 
associated with nucleocytoplasmic shuttling as well as surveillance and mRNA 
splicing (Ewing et al., 2007). In the YTH screen Cactin was identified to interact 
with a negative elongation factor subunit E (NELF-E), which is also known as RD 
RNA-binding protein (RDBP). RDBP co-operates with another complex, DRB-
sensitive factor (DSIF), to repress transcription elongation by RNA polymerase II 
(Lehner et al., 2004). Additional proteins besides Cactin that were identified in 
this screen were co-factor of BRCA1 (COBRA1), which when bound to DNA 
triggers large scale chromatin remodeling (Ye et al., 2001) and NCORI, which 
recruits a co-repressor complex containing histone deacetylases (HDACs) and 
re-presses transcription by chromatin modifications (Jepsen and Rosenfeld, 
 101 
2002). These results suggest that the NELF-E is repressing transcription 
elongation by affecting chromatin structure (Lehner et al., 2004).  
 
In this chapter the function of TgCactin was dissected using the same tools as 
applied in the described model organisms. Consistent with previous Cactin 
studies, we also identified Cactin in association with DNA/RNA processing 
proteins. Moreover, I performed genome-wide transcriptional profiling on 
TgCactin ts mutant FV-P6 to identify genes whose expression is controlled by 
TgCactin. Under restrictive condition the spurious expression of genes 
exclusively expressed in Toxoplasma cat life stages was identified. Taken 
together these results suggest an epigenetic role for Cactin, which in 
Toxoplasma appears to function as a repressor of gene expression. 
 
B4. Results 
1. TgCactin localizes to the nucleus 
Sequence analysis of TgCactin identified a nuclear localization signal (NLS) 
(MGKKRRKHDGS...) at the N-terminus (Chapter III). To assess localization of 
TgCactin in Toxoplasma tachyzoites, the yellow fluorescent protein (YFP) was 
fused to either  the C- or N-terminus of TgCactin and driven by either the strong 
α-tubulin or endogenous promoter in transfection experiments. This revealed 
nuclear localization of the TgCactin YFP fusion protein indifferent of the cell cycle 
phase, localization of the YFP fusion, or promoter in transient transfections (Fig. 
4-1). However, parasites stably expressing YFP-tagged TgCactin were only 
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obtained with N-terminus fusions of TgCactin indicating a free C-terminus is 
needed for correct function. Importantly, mutant FV-P6 could be complemented 
with YFP-, HA-, and RFP-TgCactin constructs indicating the fusion proteins are 
functional. 
 
2. Genome-wide expression array profiles confirms the arrest of FV-P6 in 
G1 
 Since TgCactin localizes to the nucleus and possesses a cyclin α-fold (Chapter 
III), I wanted to access TgCactin’s role in cell cycle and transcription regulation. 
Hereto genome-wide expression profiling was performed on FV-P6 and 
complemented FV-P6 (FV-P6 + TOXOA93) that were grown at permissive and 
restrictive temperatures. Total RNA samples were prepared and expression 
assessed using a Toxoplasma Affymetrix gene chip containing probes for all 
predicted genes in the genome (ToxoDB). The microarray data demonstrated a 
wide range of differential gene expression in FV-P6 between the permissive and 
restrictive temperatures whereas expression profiles from complemented FV-P6 
displayed even profiles when both temperatures are compared (Fig. 4-2). The 
analyses of the array data identified 300 genes with an over 2-fold differential 
mRNA expression profile in FV-P6 (Fig. 4-3 A): 267 genes were up- and 33 
down-regulated. In case of the complemented mutant, 85 genes were at least 2-
fold downregulated compared to 154 upregulated. Out of these genes 74% were 
annotated as hypothetical proteins preventing me from deducting function of 
these genes and pathways they affect. Comparative analysis of the FV-P6 gene 
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list to genes periodically expressed throughout the tachyzoite cell cycle identified 
83 genes (Fig. 4-3 B), whose expression peaks in G1 and dips in the S/M phase 
(Behnke et al., 2010). This provides additional evidence that induced FV-P6 
arrests in the G1 stage of the cell cycle. 
 
3. Genome-wide expression array profiles identify the upregulation of 
bradyzoite and cat stage specific genes in FV-P6 
Further analysis of the genome-wide profiling data revealed that 163 genes in the 
data set are associated with parasites undergoing differentiation to the bradyzoite 
stage. These included 7 surface associated genes (SAGs) and SRS genes of the 
Toxoplasma’s surface coat that were linked with expression during conversion to 
bradyzoites (Soete et al., 1994; Jung et al., 2004; Saeij et al., 2008). In addition, 
72 of the genes were representative of pH induced differentiation (Behnke et al., 
2008). Such large group of differentiation genes can be attributed to stress of 
growth at 40°C, however only 17 of differentiation specific genes were found in 
the complemented FV-P6, indicating that temperature stress alone cannot 
account for the large groups of bradyzoite genes observed in induced FV-P6 
(Figure 4-2 B). In addition, the set of 20 genes consisting mostly of hypothetical 
and surface coat genes was shared between the two strains. More strikingly, 19 
genes upregulated in induced FV-P6 are exclusively found in the sexual 
development stages only occurring upon infection of a cat (unpublished data, 
Boothroyd lab). In summary, detailed analysis of the expression profile data 
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identified genes not associated with the tachyzoite life stage, surprisingly 
including a set of sexual development cycle genes. 
 
4. Induced FV-P6 expresses bradyzoite surface markers  
Because a large number of FV-P6 genes upregulated at the restrictive 
temperature had a bradyzoite signature I investigated whether these results were 
also reflected on the protein level. For this purpose I used three antibodies 
recognizing bradyzoite specific surface antigens in immunofluorescence 
experiments. All three antibodies readily recognized bradyzoites induced by CO2 
depletion (Fig. 4-4 B), however only SRS9 Ab was able to react to FV-P6 surface 
antigens after incubation at 40°C (Fig. 4-4 D).  
 
Furthermore, the microarray data identified Cytochrome oxidase I (CoxI) to be 
17-fold downregulated, the most from all the genes. CoxI is a mitochondrial gene 
in the electron chain transport chain (Tsukihara et al., 1996). It is known that 
bradyzoite differentiation can be induced due to loss of mitochondrial integrity 
(Ferreira da Silva Mda et al., 2008). As such, I investigated whether FV-P6’s 
mitochondria are intact by using a mitochondrial dye, MitoTracker, which only 
stains active mitochondria (Lin et al., 2009). The dye stained FV-P6’s 
mitochondria at 35°C but not at 40°C demonstrating that the mitochondria are 
compromised at the restrictive temperature. 
 
5. TgCactin is present in 720 and 800 kDa complexes 
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Analyses of Cactin in various organisms demonstrated that Cactin co-
immunoprecipitates with other proteins (Lin et al., 2000; Lehner et al., 2004) 
indicating that Cactin exists in a complex with other proteins. To assess whether 
TgCactin is present in a complex I performed Native Blue Gel Electrophoresis on 
parasites expressing an HA-tag fusion of Cactin. Parasite lysates were generated 
by different detergents and immunoblotted with HA antibody. These blots 
identified two large bands of approximately  720 and 800 kDa (Fig. 4-6) indicating 
that TgCactin is present in protein complexes. 
 
6. Ten potential TgCactin interacting proteins are identified by YTH 
The strong evidence that TgCactin forms protein complexes prompted an effort 
to identify its binding partners. Extending on published studies wherein proteins 
in complex with Cactin were identified, I pursued YTH (Lin et al., 2000; Lehner et 
al., 2004). Two YTH screening rounds of a RH tachyzoite cDNA library (Kvaal et 
al., 2002) using TgCactin as  bait resulted in 48 positive hits, including a partial 
and a full length TgCactin, out of a total of 36,600 colonies screened (Fig. 4-7 
and Table 4-2). All the 48 initial TgCactin interactors were validated through one-
on-one YTH transformations with TgCactin and 10 interactors were selected for 
further analysis (Fig. 4-8). The inserts of all 48 clones were sequenced and 
identified as 41 unique genes. Based on potential functions of these genes they 
were divided into 6 groups. The first group (10 clones) consisted of genes 
involved in transcription and translation. In general, such genes are expressed in 
G1 phase. Several of the genes in this group were identified more than once: 2 
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clones encoded Translation Initiation Factor SUI, 3 clones encoded Ribosomal 
Protein L12, and 2 clones encoded the same DNA helicase. The second, third, 
and fourth group contained genes in ion transport/binding (3 genes), metabolism 
(4 genes) and genes with an unknown function (8 genes), respectively. Another 
interesting hit was a full length TgCactin and Cactin clone (Clone# 7) containing 
only the C-terminal exons 7-9 including the stop codon (amino acids 368-703), 
which showed strong interaction. Finally, the largest group, labeled as other, 
consisted of genes involved in various cellular processes ranging from invasion 
to mitochondrial transport and actin depolymerization, which appeared to be one-
off hits not grouping in a coherent function or pathway (Table 4-2).  
 
7. Ten  representative TgCactin interactors identified by YTH do not interact 
with the FV-P6 TgCactin allele or with Clone# 7  
To further determine the mechanism underlying the function of TgCactin and its 
ts allele found in FV-P6, I selected 10 YTH clones for more detailed studies. This 
subset was selected based on the robust interaction with TgCactin as well as 
reflected in the function of proteins that were found to interact with Cactin in 
previous metazoan studies (Lin et al., 2000; Lehner et al., 2004). Therefore, the 
list consists of genes involved mainly in transcription and translation regulation 
(Fig. 4-8).  
 
First, I confirmed the strength of the interactions of these genes through one-on-
one transformations with TgCactin through YTH (Fig. 4-9). Since the FV-P6 point 
 107 
mutation in TgCactin abolished its function, next I wanted to determine the 
strength of interaction of these candidate genes with the mutant TgCactin allele. 
These YTH results demonstrated that the interactions for 9 candidates were 
completely abolished whereas the RNA helicase had a 4-fold decrease in 
interaction strength (Fig. 4-10). The YTH screen also identified a partial Cactin 
encoded in Clone# 7. This region includes the so-called weakly conserved linker 
region preceding the highly conserved C-terminus and extends to the stop 
codon. This clone was tested using the same assay to assess interaction with full 
length TgCactin by YTH. Only the RNA helicase demonstrated a weak interaction 
with Clone# 7, which exhibited a 9-fold decrease compared to the wild type 
TgCactin (Fig. 4-10). 
 
8. RNA helicase localizes to the nucleus  
All the 10 selected clones strongly interacted with wild type TgCactin when 
assessed by YTH. Subsequently, I wanted to investigate whether these 
interactions were also present in Toxoplasma. The  first step was to clone the 
full-length ORF for all these genes to construct epitope reporter fusion proteins in 
Toxoplasma expression plasmids. Several of the predicted ORFs were very long 
preventing their efficient amplification from cDNA by PCR. For several others I 
was unable to amplify the ORF, possibly due to misannotation on ToxoDB 
although the expression profile data for all but one gene, TGME49_067710, 
indicated strong expression. Taken together, 4 out of 10 candidate genes were 
successfully cloned as Myc-tag fusions: TCP1 Chaperonin, a DNA Repair 
 108 
protein, Ribosomal Protein L12, and RNA helicase. The plasmids were stably 
transfected into a parasite line already expressing an HA3-TgCactin fusion. The 
initial TgCactin interactions with the above genes were assessed through IFA.  
The RNA helicase demonstrated nuclear localization whereas all others  
localized to the cytoplasm (Fig. 4-12). 
  
9. Three out of 4 potential TgCactin interactors undergo multiple cleavage 
events 
Co-IPs were attempted to corroborate IFA localization data and to determine 
whether the putative TgCactin interacting proteins are present in a complex with 
TgCactin. The parasite lines stably co-expressing myc-tagged candidate proteins 
and HA3-tagged TgCactin were used for this purpose. As a first feasibility 
experiment parasite lysates were resolved by SDS-PAGE and immunoblotted 
using myc antibody to assess protein expression (Fig. 4-13). More than one band 
was observed for 3 out of 4 candidate proteins (Fig. 4-13). The predicted size of 
the TCP1 Chaperonin is 61 kDa but bands at 28, 42, and 51 kDa were noticed. 
The expected size of the DNA Repair protein is 226 kDa but bands at 42, 70, 97, 
and 150 kDa were observed. Finally, RNA helicase’s predicted size is 144 kDa, 
but bands of 40 and 48 kDa were detected. The presence of multiple protein 
bands implies that these proteins undergo proteolytic or cleavage events. At the 
other end of the co-IP assay, immunoprecipitation of HA3-Cactin with anti-HA 
antibody was successful since the tagged Cactin was only present in eluates 
(Fig. 4-14). However, none of the myc-tagged proteins could successfully be 
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detected in the HA3 immunoprecipitates (Fig. 4-14). These results indicate that 
TgCactin is not present in a protein complex with any of the 4 candidates. 
However, as mentioned above multiple protein bands indicated that the 3 myc- 
fusion proteins undergo multiple cleavage events and thus this finding might 
prevent determination by co-IP if the myc tag is separated from the TgCactin 
interaction domain.  Based on the current results I can only conclude that the 4th 
candidate Ribosomal protein L12 likely does not interact with TgCactin.  
 
10. Deletion studies of TgCactin demonstrated that TgCactin needs at least 
the linker and the C-terminus regions for self-interaction with the wild type 
of FV-P6 TgCactin 
The finding in the initial YTH screen that C-terminal Clone# 7 interacts with 
TgCactin prompted me to investigate which sections of TgCactin are involved in 
Cactin-Cactin self-interaction. The ts point mutation in TgCactin was mapped to  
a highly conserved 115 amino acid domain at C-terminus. This region was 
designated as Cactin Domain 4 (CD4). Different bait and prey fusions of the wild 
type TgCactin, the FV-P6 TgCactin, and the wild type Clone# 7 TgCactin were 
made to assess the interactions through one on one YTH transformations. The 
yeast bait and prey plasmid encode a Myc and HA tag, respectively. These 
epitope tags were used to validate expression of the various proteins. Yeast 
lysates of the individual transformations were screened by SDS-PAGE and 
immunoblotting and confirmed expression of all test proteins (Fig. 4-15). 
Subsequently interactions were assessed by growth of the yeast transformants 
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on agar plates with selective media. The results demonstrated that wild type 
TgCactin can interact with mutated TgCactin as well as that Clone# 7 can 
interact with FV-P6 TgCactin (Table 4-3). Taken together, this indicates that for 
Cactin self-interaction the linker region present in clone #7 is required. 
 
C4. Discussion 
In this chapter, the genome wide-expression profile demonstrated that 83 genes 
that have enhanced expression in FV-P6 at the restrictive temperature are genes 
periodically expressed in the cell cycle G1 phase. Moreover, additional genes 
that are upregulated in FV-P6 under the same conditions are of bradyzoite origin 
as well as of the cat stages of the life cycle of Toxoplasma. Furthermore, YTH 
identified 41 unique potential TgCactin interactors, which strongly interact with 
the wild type TgCactin but not with the FV-P6 TgCactin or the Clone# 7. The 
Toxoplasma studies of these interactors demonstrated that only the RNA 
helicase has a nuclear localization just like TgCactin; however no direct 
interactions between these two or any of the candidates could be validated by 
co-IP. In addition, deletion and mutation analyses studies in the yeast system 
provide evidence that the linker region is involved in Cactin self-interaction.  
 
Based on N- and C- terminal YFP fusions I conclude that TgCactin localizes to 
the nucleus (Fig. 4-1). This result is consistent with the presence of a NLS in the 
N-terminus (Chapter III). However, only the N-terminal YFP fusion was tolerated 
to establish stably transfected parasites. These findings imply that C-terminal 
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fusion of TgCactin interferes with the functionality of the protein. Since, the C-
terminus of Cactin contains a highly conserved domain, free accessibility of this 
domain appears to be crucial for activity.  
 
The genome-wide expression profile study showed that over one fourth of the 
upregulated genes of FV-P6 at the restrictive temperature are indicative of G1 
phase arrest (Fig. 4-3 B). These data corroborate the G1 arrest observed by flow 
cytometry and IFAs (Chapter II). Furthermore, 163 of the upregulated genes are 
in wild type parasites only observed in the bradyzoite stage. Moreover, 72 of 
these genes are specifically induced by high pH triggered bradyzoite 
differentiation (Behnke et al., 2008). The most downregulated gene at 40°C was 
Cox I, which is present in mitochondria. Since interference with mitochondrial 
function has been shown to induce bradyzoite formation (McFadden et al., 2000), 
one possibility is that the ts mutation in TgCactin somehow leads to shut down of 
the mitochondria and subsequently to bradyzoite differentiation. Although I was 
able to show inactivation of the mitochondria (Fig. 4-5), at this point it cannot be 
confirmed whether this is a cause or effect phenomenon. In other words, is the 
mutation in TgCactin causing shut down of mitochondria and bradyzoite 
differentiation or incubation of FV-P6 at the restrictive temperature causes 
mutant’s death first which results in loss of mitochondrial integrity. The flow 
cytometry data (Chapter II) hint that at 36 hrs post incubation at the restrictive 
temperature the majority of parasites die as evident by significant increase in 
number of parasites with nuclear content of less then 1N. Therefore it is possible 
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that the shut down of mitochondria is associated with dying parasites and 
independent of bradyzoite differentiation. In addition, the IFAs of FV-P6 at the 
restrictive temperature with bradyzoite specific markers demonstrated that 60% 
of vacuoles are positive for SRS9 at 24 hrs and about 52% at 48 hrs. The slight 
decrease in number of SRS9 positive vacuoles at 48 hrs might be attributed to 
mutant’s death. 
 
Besides the bradyzoite specific genes, a set of 19 genes normally exclusively 
expressed in the cat stages of Toxoplasma were identified in induced FV-P6 
parasites (Table 4-1). Out of these genes 15 are hypothetical however 6 of them 
have homologs in Plasmodium of which 5 have no known cellular functions. 
Three of these genes are upregulated at various points of gametogenesis 
(PlasmoDB). Moreover, one of these genes, 59.03446, is an ortholog of 
PF14_0652, also known as D13, which has been shown to be upregulated in 
Plasmodium during schizogony (Daubenberger et al., 2003). Toxoplasma 
undergoes a similar division process called endopolygeny in its definitive host, 
the cat (Ferguson et al., 2007). It is rather striking to observe the upregulation of 
genes specific to the cat stages in induced FV-P6. Such finding would imply that 
the ts mutation in TgCactin causes de-repression of certain genes that are 
normally dormant in the intermediate host. This suggests that loss of TgCactin 
results in derepression of these genes and that TgCactin thus works as a 
repressor of the stage conversion specific genes. In support of this hypothesis an 
observed repressor function of Cactin has been shown in humans (Atzei et al., 
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2010a). In this study, hCactin was reported to localize to the nucleus and repress 
activation of TLRs and IRFs (Atzei et al., 2010a). On the other hand, in 
Drosophila Cactin was proposed to have a positive role in activating the Rel 
pathway by binding to Cactus and enhancing degradation of Cactus by 
proteosome enabling nuclear translocation of Rel family transcription factors (Lin 
et al., 2000). These opposite findings suggest that homology relationship 
between proteins not always translates to function conservation (Jensen, 2001). 
Since in Drosophila Cactin is found in the cytoplasm and its mode of action is 
different, the human study appears to be more consistent with my findings in 
Toxoplasma. 
 
Since various studies demonstrated interaction of Cactin with other proteins I 
investigated whether TgCactin is present in a protein complex. First, I determined 
that TgCactin could be detected in a 720 and 800 kDa in parasite lysates  (Fig. 4-
6). To identify potential TgCactin binding partners, TgCactin was used as a bait 
to screen a RH tachyzoite two-hybrid cDNA library (Kvaal et al., 2002). Forty-one 
unique positive clones were identified as potential TgCactin interactors, (Fig. 4-
7), which were grouped into 6 different functionally related groups. Based on the 
functional groups of identified candidates as well as on the set of genes identified 
to interact with Cactin in human studies, RNPS1 and NELF-E (Lehner et al., 
2004; Ewing et al., 2007), I selected 10 candidates for further functional studies 
(Fig. 4-8). Since expression of the genes in the first group 
(transcription/translation) is typically induced in G1 and the FV-P6 ts-allele of 
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TgCactin causes G1 arrest (Chapter II), 8 out of the 10 genes selected are from 
this group. In addition, the TCP-1 Chaperonin and Zinc Transporter genes 
belonging to the incoherent groups were selected since they both displayed very 
strong TgCactin interaction in YTH (Table 4-2). In addition, it is possible that 
Cactin is folded by TCP-1 containing chaperonins, which could explain such 
interaction (Sternlicht et al., 1993).  
 
The selected 10 genes were re-tested by YTH for interaction with the FV-P6 
mutant TgCactin allele as well as for interaction with the short clone of TgCactin 
identified by YTH (Clone# 7). In contrast to the interactions observed with the 
wild type full-length TgCactin, only the RNA helicase weakly interacted with these 
baits; none of the others displayed any interaction (Fig. 4-10 and 4-11). The 
negative results for the FV-P6 allele of TgCactin were rather surprising since all 
the YTH experiments are conducted at 30°C (optimal yeast growth) whereas 
mutant FV-P6 grows fine at 35°C and the mutation is only lethal at 40°C. 
Therefore, these results appear to imply that this ts TgCactin allele in yeast has 
an inhibitory affect on protein-protein interactions at lower temperatures as well. 
The lack of interactions between Clone# 7 and the above 10 interactors can be 
explained by absence of critical domains located in more N-terminal portion of 
TgCactin, which could be necessary for interaction with these 10 genes. The 
middle of TgCactin harbors a conserved so-called mid-Cactin region of unknown 
function, which is absent from C-terminal Clone# 7. Therefore it is tempting to 
speculate that either the N-terminus or mid-Cactin region is involved in 
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interactions with these 10 TgCactin interactors. On the other hand, Cactin 
interaction with itself appears to localize to the C-terminus (Table 4-3). The Clone 
#7 indicates that the strongly conserved C-terminus is involved but not 
exclusively required for TgCactin self-interactions i.e. presence of the linker 
region is required for interaction with full-length Cactin. 
 
To validate the YTH interaction in Toxoplasma 4 of the 10 interactors were stably 
transfected as c-Myc epitope-tag fusions at the N-terminus in a parasites strain 
already stably expressing HA3 tagged TgCactin. The 4 candidates were: 
Ribosomal Protein L12, TCP-1 Chaperonin, DNA Repair protein, and RNA 
helicase. The first three constructs, unlike Cactin, did not localize in the nucleus 
(Fig. 4-1). Initially no stable transfectants could be obtained for the RNA helicase. 
To by-pass this problem I created a conditional allele of this protein by fusing it to 
the DD-domain (Herm-Gotz et al., 2007). Upon addition of the stabilizing Shield-1 
ligand, c-Myc-tagged RNA helicase did localize to the nucleus (Fig. 4-12). To test 
for the presence of HA3-TgCactin in a complex with the Myc-tagged RNA 
helicase, as well as the three other candidates, co-IPs using HA-antisera were 
performed. Although I was able to efficiently pull-down HA3-Cactin in all cases 
(Fig. 4-14), none of the four c-Myc-tagged candidates co-IPed (data not shown). 
One observation that could possibly explain the lack of co-IPs is the protein 
cleavage events observed by Western blot using c-Myc antibody for all 
candidates except Ribosomal Protein L12 (Fig. 4-13). In fact, no full-length size 
bands at all could be detected for RNA helicase, TCP-1 Chaperonin, and DNA 
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Repair. If protein cleavage separates the TgCactin interaction domain from the c-
Myc-tag a co-IP cannot be detected with the current approach. To address this 
problem the c-Myc tag could be placed at the C-terminus of the candidate genes. 
However, this model cannot explain the lack of co-IP of the Ribosomal Protein 
L12. It is possible that the interaction of this and possibly the other proteins is 
very transient thereby preventing a co-IP since the interaction is too weak. 
Crosslinking of the lysates with formaldehyde prior to the co-IP could stabilize 
these interactions and make them detectable by co-IPs.  
 
In summary, the function of TgCactin was dissected by using the genome wide-
expression profile, YTH and co-IPs. As in previous Cactin studies, we also 
identified TgCactin in an association with DNA/RNA processing genes (Lehner et 
al., 2004; Ewing et al., 2007). In addition, the transcriptional profiling on a 
temperature sensitive TgCactin identified multiple genes which expression is 
controlled by TgCactin including genes exclusively expressed in Toxoplasma cat 
life stages. These data suggest a potential epigenetic role for TgCactin, which at 
least in Toxoplasma appears to function as a repressor of gene expression.  
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Figure 4-1. TgCactin localizes to the nucleus throughout the cell cycle 
A parasite line stably expressing H2b-RFP was transfected with ptub-TgCactin-
YFP/sagCAT (A) and ptub-YFP-TgCactin/sagCAT (B) constructs. Live parasites 
were imaged with a Zeiss Axiovert 200M wide-field fluorescence microscope. 
The top panels show parasites in division (M/C); the lower panel shows parasites 
in interphase (G1). 
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Figure 4-1. TgCactin localizes to the nucleus throughout the cell cycle 
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Figure 4-2. Genome-wide expression profiles of FV-P6 identified genes that   
are highly up- and downregulated at 40°C 
Affymetrix chips covering over 8000 predicted T. gondii genes were probed with 
total RNA of FV-P6 and FV-P6 + TOXOA93. Both strains were grown for 24 hrs 
at 35°C followed by induction of the phenotype for 24 hrs at 40°C, while controls 
were incubated at 35°C for the same period. The data identified 300 genes in FV-
P6 that were at least 2-fold down/up regulated at 40°C when compared to 35°C. 
The gene that was the most downregulated was Cytochrome oxidase I (Cox I) 
whereas 584.m05990, hypothetical gene, was the most upregulated. Note that 
FV-P6 genes show a high range of up/down regulation whereas FV-P6 + 
TOXOA93’s gene regulation is relatively modest.  
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Figure 4-2. Genome-wide expression profile of FV-P6 identified genes that   
are highly up- and downregulated at 40°C 
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Figure 4-3. Summary of genome-wide Affymetrix expression profile of FV-
P6 at 35°C vs. 40°C 
(A) The microarray results were divided into 2-fold up- and downregulated genes 
for FV-P6 and FV-P6 + TOXOA93. Only 20 genes are common in both data sets. 
(B) Distribution of genes by type in the FV-P6 data set as follows: Diffr. = 
tachyzoite to bradyzoite differentiation; pH = acidic pH induced differentiation; cell 
cycle = genes with cell cycle periodicity; Cat = genes expressed exclusively 
during Toxoplasma’s life cycle in the cat. 
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Figure 4-3. Summary of genome-wide Affymetrix expression profile of FV-
P6 at 35°C vs. 40°C 
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Figure 4-4. FV-P6 has a bradyzoite signature of SRS9 at 40°C 
Pru, 2F-1-YFP2 (parent), and FV-P6 tachyzoites were grown under (A) standard 
(5% CO2 conditions) and (B) bradyzoite induction (environmental CO2 conditions) 
for three days. IFAs with bradyzoite specific surface markers (C) SAG2Y Ab, (D) 
SRS9 Ab, and (E) Dolichos bifloris lectin were performed and the parasites were 
scored for the bradyzoite phenotype. The 2F-1-YFP2 and FV-P6 tachyzoites 
were incubated at (F) 35°C and (G) 40°C for 24 and 48 hrs and checked by IFA 
with above bradyzoite markers for differentiation. Only the SRS9 marker was 
specifically enhanced in FV-P6 at 40°C (G).  
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Figure 4-4. FV-P6 has a bradyzoite signature of SRS9 at 40°C 
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Figure 4-5 FV-P6’s mitochondria are compromised at 40°C 
(A) Normalized microarray expression values of Cox I in FV-P6 at 35°C and 
40°C. (B-E) FV-P6 and (F-I) 2F-1-YFP2 (parent) were grown at 35°C (B,C) FV-
P6 and (F,G) 2F-1-YFP2 as well as at 40°C (D,E) FV-P6 and (H,I) 2F-1-YFP2. 
The strains were subsequently stained with the mitochondrion specific dye 
(MitoTracker). MitoTracker only stains mitochondria with an intact membrane 
potential. Note lack of mitochondrial staining in FV-P6 incubated at 40°C (D,E).  
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Figure 4-5. FV-P6’s mitochondria are compromised at 40°C 
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Figure 4-6. TgCactin is present in 720 and 800 kDa complex 
The stable clone of FV-P6 complemented with HA3wtCactin was lysed under 
native conditions with lysis buffers containing three different detergents:  Triton-
X-100 (TX-100), Dodecyl Maltoside (DDM), and Digitonin (DIG). The parasite 
lysates were resolved by Native Blue Gel Electrophoresis and immunoblotted 
with HA antibody. The red arrows indicate Cactin complexes at 720 and 800 kDa.  
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Figure 4-6. TgCactin is present in 720 and 800 kDa complex  
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Figure 4-7. Potential TgCactin interacting proteins identified by yeast-two 
hybrid screening 
TgCactin was used as a bait to screen a tachyzoite YTH cDNA library for 
potential interactors using the GAL4-based yeast two-hybrid system. The screen 
identified 41 unique potential interactors, which can be divided in 6 major groups: 
Transcription/Translation (10), Ion transport and binding (3), Metabolism (4), 
Unknown/Not Annotated (8), TgCactin Clones, that included a full length and a 
partial TgCactin clones, and Other (15).  
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Figure 4-7. Potential TgCactin interacting proteins identified by yeast-two 
hybrid screening 
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Figure 4-8. Ten yeast two-hybrid TgCactin Interactors selected for further 
validation 
The 10 potential interactors selected for further one on one validations with 
TgCactin, FV-P6 TgCactin, and Clone# 7. The numbers in the circles refer to the 
clone name. 
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Figure 4-8. Ten yeast two-hybrid TgCactin Interactors selected for further 
validation 
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Figure 4-9. Wild type TgCactin bait interacts strongly with all 10 selected 
interaction candidates 
One-on-one transformations of Cactin and all 10 interactors were used to 
validate the strength of TgCactin interactions. Following the transformations the 
transformants were grown on plates with increasing 3-Aminotriazole 
concentrations and X-α-Gal substrate, respectively. The bars indicate the 
strength of these interactions on 3-Aminotriazole and the blue color refers to 
intensity of X-α-Gal interaction. The dark shade of blue visible in this graph for all 
10 potential TgCactin interactors demonstrates strong interactions. 
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Figure 4-9. Wild type TgCactin bait interacts strongly with all 10 selected 
interaction candidates 
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Figure 4-10. The FV-P6 TgCactin allele weakly interacts with only RNA 
helicase 
One on one transformations of FV-P6 TgCactin and all 10 interactors were used 
to validate the strength of TgCactin interactions. Following the transformations 
the transformants were grown on plates with increasing 3-Aminotriazole 
concentrations and X-α-Gal substrate, respectively. The bars indicate the 
strength of these interactions on 3-Aminotriazole and the blue color refers to 
intensity of X-α-Gal interaction. In this graph all the interactors with TgCactin 
except for RNA Helicase were abolished. Moreover, RNA Helicase interacted 
weaker with FV-P6 TgCactin, as depicted by lighter shade of blue, than wild type 
TgCactin (Fig. 4-9).  
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Figure 4-10. The FV-P6 TgCactin allele weakly interacts with only RNA 
helicase  
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Figure 4-11. The partial Clone# 7 of TgCactin (amino acids 368-703) 
interacts very weakly only with RNA helicase 
One on one transformations of partial TgCactin and all 10 interactors were used 
to validate the strength of TgCactin interactions. Following the transformations 
the transformants were grown on plates with increasing 3-Aminotriazole 
concentrations and X-α-Gal substrate, respectively. The bars indicate the 
strength of these interactions on 3-Aminotriazole and the blue color refers to 
intensity of X-α-Gal interaction. In this graph all the interactors with TgCactin 
except for RNA Helicase were abolished. Moreover, RNA Helicase interacted 
weaker with the partial Clone# 7 TgCactin, as depicted by lighter shade of blue, 
than wild type TgCactin (Fig. 4-9) and FV-P6 TgCactin (Fig. 4-10). 
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Figure 4-11. The partial Clone# 7 of TgCactin (amino acids 368-703) 
interacts very weakly only with RNA helicase 
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Figure 4-12. The RNA helicase and HA3-TgCactin localize to the nucleus; 
TCP1, DNA Repair and Ribosomal Protein L12 localize to the cytoplasm 
(A,B) A stable line of RH transfected with HA3wtCactin was made to confirm the 
interactions identified by the yeast two-hybrid screen. The IFA was performed 
with a rat monoclonal 3F10 HA antibody to demonstrate Cactin’s nuclear 
localization. The above strain was then used to generate stable lines with Myc-
epitope fusions of potential Cactin interactors identified in the yeast two-hybrid. 
The stable clones were then probed with a mouse monoclonal 9E10 antibody for 
localization and the nucleus was stained with DAPI; (C,D) Myc2-TCP1 
Chaperonin, (E,F) Myc2-DNA Repair, (G,H) Myc2-Ribosomal Protein L12, (I,J) 
DD-Myc-RNA helicase.  
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Figure 4-12. The RNA helicase and HA3-TgCactin localize to the nucleus; 
TCP1, DNA Repair and Ribosomal Protein L12 localize to the cytoplasm 
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Figure 4-13. Parasite lysates contain processed forms of epitope tagged 
TCP1, DNA Repair and RNA helicase proteins 
The stable lines in Figure 4-12 were checked for expression of myc fusion 
proteins. The expected sizes of expressed proteins are: Myc2-TCP1 Chaperonin 
(61 kDa), Myc2-DNA Repair (226 kDa), Myc2-Ribosomal Protein L12 (21 kDa), 
DD-Myc-RNA helicase (144 kDa). The lysates were resolved on 12% SDS-
PAGE, blotted, and subsequently probed with a mouse monoclonal Myc 9E10 
HRP-conjugated antibody.   
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Figure 4-13. Parasite lysates contain processed forms of epitope tagged 
TCP1, DNA Repair and RNA helicase proteins 
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Figure 4-14. HA3-TgCactin can be immunoprecipitated 
The HA3wtCactin protein was immunoprecipitated from a stable line of 
expressing HA3wtCactin with the agarose beads conjugated to an anti-HA rat 
monoclonal 9F10 antibody. All the steps of the immunoprecipitation process were 
resolved on 12% Bis-Tris, blotted, and subsequently probed with an anti-HA rat 
monoclonal  antibody (3F10). 
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Figure 4-14. The HA3-TgCactin can be immunoprecipitated 
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Figure 4-15. TgCactin fusions for self-interactions are expressed in yeast 
Yeast lysates containing combinations of TgCactin, Clone# 7, and mutated FV-
P6 Cactin version of bait and prey constructs that were transformed into yeast to 
probe TgCactin self interactions. The bait constructs are designated with BD 
(DNA binding domain) and the prey constructs with AD (DNA Activation domain).  
The abbreviation Fl refers to a full length TgCactin and Clone# 7 refers to Exons 
7-9 of TgCactin; wt refers to wild type whereas mut refers to mutated version of 
TgCactin identified in FV-P6. pSE1111 and pSE1112 designate YTH controls 
(SNF 4 and 1, respectively). The respective size of full length TgCactin is 107 
kDa and Clone# 7 is 70 kDa. The lysates were probed with HA Ab (3F10) for 
preys (A) and with Myc Ab (9E10) for baits (B).  
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Figure 4-15. TgCactin fusions for self-interactions are expressed in yeast 
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Table 4-1.  List of cat stage specific genes expressed in FV-P6 at 40°C 
 
GENE ID Annotation 
49.m03245 molybdenum cofactor biosynth. protein  
80.m02121 hypothetical 
44.m02559 hypothetical 
76.m01632 hypothetical 
42.m03312 hypothetical 
59.m03446 homolog of D13 
583.m05590 hypothetical 
29.m00019 hypothetical 
65.m02516 hypothetical 
59.m07738 SRS34B 
541.m01242 hypothetical 
65.m01106 hypothetical 
80.m02339 hypothetical 
59.m03729 protein kinase (incompl. catalytic triad) 
20.m03841 hypothetical 
583.m05715 hypothetical 
20.m05935 hypothetical 
83.m02139 hypothetical 
74.m00457 hypothetical 
 
 
 148 
Table 4-2. The list of 41 potential TgCactin interactors identified in the YTH 
screens 
TgCactin interactors identified through YTH with TgCactin as bait. The hits were 
grouped in 6 sets based on potential functions within the cell. These groups are: 
Transcription/Translation (10 candidates), Ion Transport/Binding (3), Metabolism 
(4), Unknown/Not Annotated (8), TgCactin Clones (1), and Other (15). The 
numbers in Clone Name column refer to the order the clones were identified in 
the screens. The designation “T2” refers to the second screen and “Slow” refers 
to the clones that took at least 7 days to grow on QDO (Trp-, Leu-, Ade-, His-) 
plates.  
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Table 4-2. The list of 41 potential TgCactin interactors identified in the YTH 
screens 
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Table 4-2. The list of 41 potential TgCactin interactors identified in the YTH 
screens 
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Table 4-2. The list of 41 potential TgCactin interactors identified in the YTH 
screens 
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Table 4-3. Table of Cactin-Cactin interactions determined through YTH 
The wild type (wt) Cactin, mutated (mut) FV-P6 Cactin, and the partial Clone# 7 
versions of bait (BD) and prey (AD) were made to assess Cactin self-interactions. 
Plus “+” indicates interaction and minus “-“ indicates no interaction. 
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Table 4-3. Table of Cactin-Cactin interactions determined through YTH 
 
 
Construct 
 
wtCactin-AD 
 
mutCactin-AD 
 
Clone#7-AD 
wtCactin-BD + + + 
mutCactin-BD + - + 
Clone#7-BD + + - 
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CHAPTER V 
CONCLUSION AND FUTURE DIRECTIONS  
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A5. Conclusion 
Acute infection of Toxoplasma in immunocompetent patients is curbed by the 
adaptive immune response, which causes conversion of the acute tachyzoite 
stage into latent bradyzoites. Latent infection is maintained life long and upon 
immunosuprression, bradyzoites can revert back into the acute tachyzoite stage 
leading to life-threatening disease. Furthermore, the fetus has an immature 
immune system and therefore congenital infection can lead to major damage to 
the unborn child (Montoya and Liesenfeld, 2004). Virulence of parasite infection 
has been correlated with the tachyzoite’s growth rate, which is a general 
pathogenicity factor in apicomplexan parasite caused diseases (Diffley et al., 
1987).  
 
In Toxoplasma, it has been shown that the length of the G1 cell cycle phase is 
significantly shortened in the most virulent Type I strains  indicating a mechanism 
behind enhanced virulence (Radke et al., 2001). In this thesis I demonstrated 
that mutant FV-P6 arrests in the G1 phase of the cell cycle (Chapter II). In 
addition, I identified the allele responsible for this phenotype to reside in a 
TgCactin point mutation (Chapter III). Therefore, TgCactin is of high interest to 
understand control of G1 stage progression and in turn can provide insight in the 
virulence of the parasite. 
 
Genome-wide expression profiling of induced FV-P6 identified 163 upregulated 
genes normally found in parasites undergoing bradyzoite differentiation (Chapter 
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IV) (Behnke et al., 2010). Since these genes were not expressed in 
complemented parasites grown at 40°C, I can exclude the possibility that these 
genes are the result of temperature stress and therefore are specifically 
associated with the phenotype. Another striking set of genes expressed in 
induced FV-P6 were those associated with the sexual life cycle stages of 
Toxoplasma, which only develop in the small intestine of the cat. These results 
indicate that loss of TgCactin results in misregulation of gene expression and 
therefore the most logical role for TgCactin would be as a suppressor of gene 
expression:  i.e. when TgCactin becomes compromised, like due to the point 
mutation in FV-P6, the set of genes that normally should be repressed gets 
activated in the tachyzoite stage.  
 
In human studies, Cactin was identified to play a role in mRNA splicing (Ewing et 
al., 2007) and to repress transcription elongation by RNA polymerase II (Lehner 
et al., 2004). In addition, hCactin was recently identified as a nuclear factor that 
co-immunoprecipitated with I-kappa-BL (IκBL) (Atzei et al., 2010a), a nuclear 
member of the IκB family proteins, which inhibits activation of the NFκB 
(Baeuerle and Henkel, 1994). Furthermore, hCactin was shown to be a repressor 
of Toll-like receptors (TLRs) and interferon regulator factors (IRFs) (Atzei et al., 
2010a), which facilitate immune responses. On the other hand, in Drosophila the 
opposite result was observed as DmCactin was demonstrated to activate the 
NFκB pathway (Lin et al., 2000). These results demonstrate that Cactin can have 
totally opposite affects on the same pathway depending on the organism. 
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To further elucidate the role of TgCactin I performed a YTH screen to identify 
potential interacting proteins, which could shed a light on the mechanism of 
action (Chapter IV). The most coherent group of genes identified was a set of 10 
proteins forming the Transcription/Translation group, which included RNA and 
DNA helicases. In plants such RNA/DNA helicases are involved in a series of 
processes ranging from splicing, replication, translation initiation, editing, rRNA 
processing, ribosome assembly, nuclear mRNA export, early stage pre-rRNA 
processing, DNA repair, translation initiation, and cell division/proliferation 
(Luking et al., 1998; Tuteja, 2003). In general, sequence comparisons of 
Toxoplasma proteins reveal that they share a high degree of homology with plant 
proteins e.g. the model plant Arabidopsis thaliana. For example, a BLAST search 
with the RNA helicase identified through the TgCactin YTH screen demonstrated 
a 50% homology to Arabidopsis thaliana gene AT2G33730 and 48% homology 
to Plasmodium falciparum gene PFE0925c. As such it can be inferred that 
Toxoplasma’s helicases would have similar functions since they share high 
homology with plants.  
 
Furthermore, in Arabidopsis proteins of the trithorax group (trxG) have been 
shown to activate developmental genes, repressed by the Polycomb group 
(PcG), through chromatin modifications, which involve ATP-dependent helicases 
(Aichinger et al., 2009). Moreover, another family of plant-like proteins that has 
recently been studied in more detail in Apicomplexa is the AP2 plant-like 
transcription factors (Jofuku et al., 1994; Balaji et al., 2005). Several members 
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were found to be very tightly expressed throughout cell cycle progression and 
several were found to be stage specific (Behnke et al., 2010). Also such AP2 TFs 
have been identified in Plasmodium (De Silva et al., 2008) and AP2-Sp has been 
shown to be involved in transcription of stage specific genes such as during 
sporozoite formation (Yuda et al., 2010). In addition, AP2-like TF in Toxoplasma 
was identified through purification of TgHDAC3, which was shown to bind the 
apicomplexan AP2, TgCRC350, (Saksouk et al., 2005) demonstrating direct 
association with histone modifying proteins (Dixon et al., 2010). 
 
Taking into account these recent findings it can be speculated that in 
Toxoplasma AP2 TFs, histone modifying enzymes, helicases and through the 
helicase association also TgCactin are involved in an epigenetic control 
mechanism of gene expression. At the moment it is unclear how the roles of all 
these actors are coordinated. However, the several lines of evidence provided 
here hint toward such a model, which will be an exciting theory to further dissect 
in Toxoplasma.  
 
Future directions 
FV-P6 mutant exhibited similar arrest at the single cell division in the G1 as 63H4 
and 31F1 ts mutants and moreover this arrest was reversible when the parasites 
were shifted back to the permissive temperature (Gubbels et al., 2008a). It would 
be interesting to determine whether these ts mutants have mutations in the same 
protein or pathway as FV-P6. A simple experiment involving transfection of 63H4 
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and 31F1 with wild type TgCactin and subsequent assessment of growth 
restoration at the restrictive temperature would demonstrate if TgCactin is 
responsible for their ts phenotype.  
 
Furthermore, native blue gel electrophoresis of HA3-TgCactin demonstrated that 
this proteins exists in complexes of 720 and 800 kDa (Chapter IV). Out of 10 
prospective TgCactin interactors 4 were c-Myc-epitope cloned and stably 
transfected into tachyzoites. To demonstrate whether these proteins form 
complexes with TgCactin the lysates generated under non-denaturing conditions 
could be run under native conditions and subsequently probed with HA and Myc 
antibodies, which are the tags of TgCactin and candidate interactors, 
respectively. If the sizes of the complexes probed with the HA and Myc 
antibodies would match that would imply that they exist in the same complex. 
 
The SDS-PAGE gel of the N-terminal Myc-tagged potential TgCactin interactors 
indicated that 3 out of 4 TgCactin interactors undergo multiple cleavage events, 
therefore if these proteins interacted with TgCactin in the portion of the protein 
that is closer to the C-terminus such bands would not appear on the gel as the 
tags are in the N-terminus. A simple swapping of the myc-epitope and putting it 
on the C-terminus would allow me to determine whether TgCactin interacts with 
these proteins at this end. The Ribosomal Protein L12 did not undergo the 
cleavage but it did not co-IP with TgCactin, either. There is a possibility that this 
interaction is transient, therefore crosslinking the proteins might preserve such 
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interactions and enable to demonstrate direct binding between the two proteins. 
If switching of the tag will not result in co-IP of TgCactin with myc2-TCP1 
Chaperonin, myc2-DNA Repair, or DDmyc-RNA helicase the crosslinking step 
might be applied prior to IP. 
 
Another way of finding TgCactin interactions would be by expressing a tagged 
version, such as an HA-epitope, of TgCactin, bind it to a matrix and use it to pull 
down proteins that would bind to the bound HA-TgCactin as parasite lysate 
passes through the column. Such bound proteins would be eluted and 
subsequently send for mass spectrophotometry to determine the TgCactin 
binding partners. 
 
Finally, a possible fruitful direction to pursue might be to identify those AP2 
transcription factors with an expression peak in early G1. For instance co-
immunoprecipitations like those observed for HDAC3 and some AP2 TFs might 
potentially form a complex with TgCactin regulating progression through G1. 
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CHAPTER VI 
MATERIALS AND METHODS 
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A6. Strains used in this study 
Parasite strains                                                                             Reference 
RH                                                                                                (Sabin, 1941) 
Pru                                                                                         (Martrou et al., 1965) 
2F-1-YFP2               (Gubbels et al., 2003) 
FV-P6                (Gubbels et al., 
2008a) 
FV-P6 + TOXOA93                                                                (Gubbels et al., 
2008a) 
FV-P6 + pIMC7-CherryRFP-IMC7/sagCAT 
FV-P6 + pIMC14-CherryRFP-IMC14/sagCAT 
RHΔhxgprt                  (Donald et al., 1996) 
RH + ptub-H2B-mRFP/sagCAT                         (Gubbels et al., 2006) 
RH + ptub-H2B-CherryRFP/sagCAT + ptub-Cactin-YFP/sagCAT 
RH + ptub-H2B-CherryRFP/sagCAT + ptub-YFP-Cactin/sagCAT 
FV-P6 + ptubHA3Cactin/sagCAT 
RH + ptubHA3Cactin/sagCAT 
RH + ptubHA3Cactin/sagCAT + ptubmyc2-TCP1 Chaperonin/dhfrDHFRdhfr 
RH + ptubHA3Cactin/sagCAT + ptubmyc2-DNA Repair/dhfrDHFRdhfr 
RH + ptubHA3Cactin/sagCAT + ptubmyc2-Ribosomal Protein L12/dhfrDHFRdhfr 
RH + ptubHA3Cactin/sagCAT + ptubDDmyc-RNA Helicase/dhfrDHFRdhfr 
 
Yeast strains 
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AH109 (MATa, trp1-901, leu2-3 , 112, ura3-52, lys2-181, his3-200, ade2-101, 
gal4-952, gal80-538, LYS2::GAL1uas-GAL1tata-HIS3, GAL2uas-GAL2tata -
ADE2, URA3::MEL1uas-MEL1tata –lacZ         (Clontech) 
AH109:pGBK-GAL4-Cactin-BD 
AH109:pGBK-GAL4-FV-P6Cactin-BD 
AH109:pGBK-GAL4-Clone# 7 Cactin-BD 
AH109:pGBK-GAL4-CD4-Cactin-BD 
AH109:pGBK-GAL4-FV-P6-CD4-Cactin-BD 
AH109:pGAD-GAL4-Cactin-AD 
AH109:pGAD-GAL4-FV-P6Cactin-AD 
AH109:pGAD-GAL4-Clone# 7 Cactin-AD 
AH109:pGAD-GAL4-Translation Initiation Factor SUI1-AD 
AH109:pGAD-GAL4-DNA Repair-AD 
AH109:pGAD-GAL4-Ribosomal Protein L12-AD 
AH109:pGAD-GAL4-Helicase-AD 
AH109:pGAD-GAL4-Transcriptional Accessory Protein-AD 
AH109:pGAD-GAL4-RNA Helicase-AD 
AH109:pGAD-GAL4-Transcriptional co-Activator-AD 
AH109:pGAD-GAL4-Nucleic Acid binding-AD 
AH109:pGAD-GAL4-TCP-1 Chaperonin-AD 
AH109:pGAD-GAL4-Zinc Transporter-AD 
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Table 6-1 Primers used for PCR amplification and cloning: restriction 
enzyme sites are underscored. 
Primers: Rev-Fusion-Cactin, For-Fusion-Cac2, and For-Myc-CD4 have AvrII site; 
Rev-Fusion-Cac2 has EcoRV site; and  For-Fusion-Cactin has BglII site. 
Primer name                                      Sequence 
Candidate gene primers 
49.m00062 
0062-F        CGTGACCACGCGAACGCCTTGG  
0062-R        CGTTGACTTCCACGTTCTGAGAATCAG 
49.m00063 
0063-F         CCCCACGGGTCGGCACGGATTTG 
0063-R         GTATCGAAAAGAGACGTGTCTCCGTTCATC 
49.m03405  
3405-F         CTGGTGTGTGAGGATGGACTCTCTTG  
3405-R         CATGCCTCGGAAAGGCACTGCAC 
49.m03404 
3404-F         CCATGGGGATTATGCGCACGGCC 
3404-R         CGCTTCAGCGTCGACAAAGTGAATCC 
YFP/RFP fusion primers 
For-Fusion-Cactin        ccgAGATCTaaaATGGGGAAAAAGCGAAGGAAGCACG 
Rev-Fusion-Cactin         gcgCCTAGGTCGGCGGTAGATGTAGCGTTTGAAGG 
For-Fusion-Cac2            ccgCCTAGGATGGGGAAAAAGCGAAGGAAGCACG 
Rev-Fusion-Cac2           gcgGATATCTCATCGGCGGTAGATGTAGCG 
IMC7-F-Avr         cagCCTAGGATGGAGTTCACTGCTGACAAC 
IMC7-R-RV         cagGATATCCTACGCAGCGATTGGGAC 
pIMC7-F-PmeI          cagGTTTAAACGTGGGCTCGTCTGGTTTTCTCCG 
pIMC7-R-BglII           cagAGATCTTGCGAAGAAGGCGTGAAAAAGCAAG 
IMC14-F-Nhe        cagGCTAGCATGGAGCTCTGCGAGAGCCCCTG 
IMC14-R-RV         cagGATATCTCACCTTTTCATAAAGTCTTCGTTG 
pIMC14-F-PmeI          cagGTTTAAACTCGCATGCTGAGGAACCAACC  
pIMC14-R-BglII          cagAGATCTCGTGTCCACTATTGGTAACGGAT  
 
HA fusion Cactin primers 
Catin-F-Xma                  ccgCCCGGGATGGGGAAAAAGCGAAGGAAGCACG 
Rev-Fusion-Cac2          gcgGATATCTCATCGGCGGTAGATGTAGCG 
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Myc fusion primers 
For-Myc-CD4                 ccgCCTAGGATGCGAAAGCCGCGGTTCTTCAATCG 
072910-F-AvrII              ccgCCTAGGATGGCGGCTGCTGACGTGGCAAC 
072910-R-EcoRV          gcgGATATCTCAGCGGCACATGACGATGTCGTC 
054440-F-AvrII              ccgCCTAGCATGGCGCCCAAATTCGACCC 
054440-R-EcoRV          gcgGATATCCTAAGCCTCGGGGCAGTCGATC 
042830-F-AvrII              ccgCCTAGGATGGGGATCGGCAGATTCTATCG 
042830-R-EcoRV          gcgGATATCTTAGCGTCTCTGCGATCCGCG 
DD system primers 
098020-F-NsiI              ccgATGCATATGTCGCCTGAGCTGGGGAG 
098020-R-PacI             gcgTTAATTAATCAATTGAACCAAATCGGCTTGATC 
 
Yeast two-hybrid Cactin primers 
Att-B1-adapt      GGGGACAAGTTTGTACAAAAAAGCAGGCT 
Att-B2-adapt      GGGGACCACTTTGTACAAGAAAGCTG 
AttB1-F-Cactin             AAAAAGCAGGCTccATGGGGAAAAAGCGAAGGAAGCACG 
AttB2-R-Cactin            AGAAAGCTGGGTgTCATCGGCGGTAGATGTAGCGTTTGAAGG 
_________________________________________________________________________ 
 
 
B6. Methods 
Plasmid constructs 
The plasmid ptub-CherryRFP2/sagCAT (kindly provided by Giel van Dooren and 
Boris Striepen, U. of Georgia) was digested with AvrII and EcoRV for N-terminal 
fusions. The IMC7 was PCR amplified with IMC7-F-Avr and IMC7-R-RV and 
digested with AvrII and EcoRV that whereas the IMC14 was PCR amplified with 
IMC14-F-Nhe and IMC14-R-RV and digested with NheI and EcoRV and ligated 
into the above vector to generate plasmid ptub-CherryRFP-IMC7/sagCAT and 
pIMC14-CherryRFP-IMC14/sagCAT, respectively. The 1500 bp endogenous 
promoters of IMC7 and 14 were PCR amplified from genomic DNA using pIMC7-
F-PmeI and pIMC7-R-BglII or pIMC14-F-PmeI and pIMC14-R-BglII primers and 
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cloned into ptub-CherryRFP2/sagCAT using PmeI/BglII resulting in plasmids 
pIMC7-CherryRFP-IMC7/sagCAT and pIMC14-CherryRFP-IMC14/sagCAT, 
respectively.  
Plasmid ptubHA3Cactin/sagCAT was generated by XmaI and EcoRV cloning of 
PCR amplified Cactin using Catin-F-Xma and Rev-Fusion-Cac2 primers into 
ptub-HA3-/sagCAT (kindly provided by Giel van Dooren and Boris Striepen, U. of 
Georgia). 
The ptubYFP2(MCS)/sagCAT plasmid (Gubbels et al., 2003) was digested with 
BglII and AvrII for C-terminal or AvrII and EcoRV for N-terminal fusions and 
cloned with Cactin amplicons that were PCR amplified with For-Fusion-Cactin 
and Rev-Fusion-Cactin or For-Fusion-Cac2 and Rev-Fusion-Cac2 and digested 
with the same enzymes to generate ptub-Cactin-YFP/sagCAT and ptub-YFP-
Cactin/sagCAT, respectively.  
TGME49_090820 (RNA Helicase) was PCR amplified with primers 098020-F-
NsiI and 098020-R-PacI and cloned into ptub8DDmycRab11b (Agop-Nersesian 
et al., 2010) using PacI and NsiI to generate ptubDDmyc-RNA 
Helicase/dhfrDHFRdhfr.  
Plasmid ptub-myc2-CactinCD4/dhfrDHFRdhfr was generated by cloning the PCR 
amplified conserved C-terminal region of Cactin (345 bp; primers For-Myc-CD4 
and Rev-Fusion-Cac2), so-called Cactin Domain 4 (CD4), into 
ptubYFP2(MCS)/sagCAT plasmid (Gubbels et al., 2003) using AvrII and EcoRV. 
Subsequently, CactinCD4dhfr was excised using AvrII and NotI and cloned into 
ptubmyc2MORN1/sagCAT (Lorestani et al., 2010) with the same enzymes 
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resulting in plasmid ptub-myc2-CactinCD4/dhfrDHFRdhfr. This plasmid was 
subsequently used to replace CactinCD4 with PCR amplified TGME49_042830 
(DNA Repair) amplicon, TGME49_054440 (Ribosomal Protein L12) amplicon, 
TGME49_072910 (TCP-1 Chaperonin) (see Table 6-1 for primers), using AvrIi 
and EcoRV enzymes. 
 
Tissue culture 
All Toxoplasma RH strain tachyzoites including ts mutants were grown in 
confluent human foreskin fibroblast (HFF) cell monolayers as described (Donald 
and Roos, 1993). In short, parasites were grown at 37°C (wt) or 35°C and 40°C 
(ts) under 5% CO2 in so-called ED1 medium: DMEM (Invitrogen) supplemented 
with 1% heat inactivated Fetal Bovine Serum (Hyclone), 0.1 mM L-glutathione 
(Sigma), and 0.5 mM Penicillin/Streptomycin (Gibco). 
 
Plaque assays 
HFF cells grown to confluence in T-175 or T-25 flasks were infected with 400, 106 
or 107 FV-P6 parasites, 102 or 103 2F-1-YFP2 parasites, or 400 RH parasites. 
Duplicate flasks for each condition were set up and both flasks incubated 
overnight at 35°C after which one set of flasks was transferred to 40°C and the 
other retained at 35°C. The flasks were left undisturbed for 7 days and 
subsequently fixed in 100% methanol and stained with 5x Crystal Violet: 12.5 g 
Crystal Violet in 125 ml ethanol combined with 500 ml 1% ammonium oxalate. 
Crystal Violet stain was then removed, flasks were rinsed twice with PBS, air 
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dried, and scored for the presence or absence of cytolytic plaques (Roos et al., 
1994). 
 
Growth curves 
HFF confluent 384-well black, optical bottom plates (BD) were infected with 103 
2F-1-YFP2, FV-P6, or FV-P6 + TOXOA93 parasites per well in a phenol free 
medium and 2-fold serially diluted to 1,000 parasites per well, in quadruple as 
described (Gubbels et al., 2003). Three plates were seeded in parallel for each 
parasite and incubated at either 35°C, 37°C of 40°C for 7 days. Fluorescence 
was measured daily on a SpectraMax M5 microplate reader at an excitation 
wavelength of 490 nm, emission of 540 nm, and cutoff of 515 nm. Individual wells 
were read six times at and readings averaged. Readings from the four replicate 
wells were then averaged and standard deviation calculated for each time point. 
Mutant growth was normalized against minimum and maximum growth values at 
each temperature of 2F-1-YFP2 and expressed as percentage positivity of the 
YFP signal (Gubbels et al., 2003). Growth curves were constructed using 
Microsoft Excel. 
 
Flow cytometric analysis of DNA material 
The DNA content of 2F-1-YFP2 and FV-P6 parasites grown at 35°C and 40°C 
was measured by flow cytometry (Gubbels et al., 2008a). In short, parasites 
grown in T-175 flasks were harvested by needle passage and 3 µm 
polycarbonate filtration followed by centrifugation and resuspension in 70% 
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ethanol in PBS. Ethanol fixation was carried out for 24 hrs at -20°C. Fixed 
parasites were pelleted at 300 x g, resuspended in 50 µM Tris pH 7.5, stained 
with 1 µM SYTOX Green (Invitrogen), and RNase treated for 30 min at room 
temperature in the dark. Fluorescence of DNA was measured with a flow 
cytometer using a FL-1 argon laser (488 nm). Fluorescence was collected in 
linear mode and 10,000 events were collected and analyzed with CELLQuest 
v3.0 (Becton-Dickson Inc.). 
 
Immunofluorescence 
HFF cells were grown on cover slips in 6-well plates , which were subsequently 
infected with variable amounts of freshly lysed parasites and grown for various 
times at various temperatures as needed. In general, infected cells were 100% 
methanol fixed for 20 min and blocked for 1 hr of overnight in 3% bovine serum 
albumin (BSA) in PBS. Cover slips containing parasites expressing HA-epitope 
protein fusions were fixed with 4% paraformaldehyde in PBS for 20 min, 
permeabilized with 0.25% Triton-X-100 in PBS for 20 min, and 1 hr or overnight 
blocked in 3% BSA in PBS. Subsequently, the cover slips were incubated for one 
hour with various antibodies; mouse monoclonal anti-α-tubulin 12G10 (1:100; 
Developmental Studies Hybridoma Bank, Univ. of Iowa), rabbit anti-IMC3 (1:500; 
(Gubbels et al., 2004)), rabbit polyclonal anti-MORN1 (1:200; (Gubbels et al., 
2006)), mouse monoclonal anti-centrin1 20H5 (1:5000; (Sanders and Salisbury, 
1994)), rabbit anti-CherryRFP (1:200,000; Ian Cheeseman, Whitehead Institute 
for Biomedical Research), rat monoclonal anti-HA Ab (3F10) (1:3,000; Roche), 
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mouse monoclonal anti-myc Ab (9E10) (1:2,000; Santa Cruz Biotechnlogy), 
Dolichos lectin directly conjugated to TRITC (1:200; Vector Labs),  rabbit anti-
SRS9 (1:200; (Kim and Boothroyd, 2005)), and  rabbit anti-SAG2Y (1:5000; 
(Saeij et al., 2008)) in blocking solution. Secondary antibodies were added to 
cover slips and incubated for one hour at a 1:200 dilution in blocking solution. 
The secondary antibodies against the mouse , rat or rabbit were conjugated to 
either Alexa Fluor 488 or Alexa Fluor 594 (invitrogen). 4’,6-diamidino-2-
phenylindole (DAPI; 1.3 ng/ml in PBS) staining was used for visualization of 
nuclear material. Coverslips were mounted on slides using gelfluor (Ambion). 
Imaging was performed on a Zeiss Axiovert 200M wide-field fluorescence 
microscope equipped with standard DAPI, FITC, YFP, and TRTC filter sets, an α-
Plan-Fluar 100x/1.45 NA oil objective, and a Hamamatsu C4742-95 camera. 
Images were analyzed and processed with Volocity (Improvision).  
 
Amplification of cosmid library DNA 
To produce wild type ToxoSuperCos cosmid library DNA, the stabilates were first 
titered  so 10,000 colonies per 150 mm diameter Petri dish containing 10 µg/ml 
Kanamycin in LB-agar (Gubbels et al., 2008a). Per DNA batch approximately 50 
150 mm plates were grown overnight at 37°C. Colonies were harvested by 
scraping and washing with LB. DNA from the collected colonies was purified 
using the DNA Purification Large Construct Kit (Qiagen) according to 
manufacturer’s instructions.  
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Cosmid growth and isolation 
Individual cosmids, TOXOA93 and TOXOD43, were obtained from a collection of 
384-well plates containing 10,000 tiled and end-sequenced individual cosmids 
(Gubbels et al., 2008a). Five ml bacterial cultures (LB/Kan) were grown for DNA 
isolations. Bacterial pellets were lysed with 250 µl of P1 buffer (Qiagen) 
supplemented with 70 µl of 10 mg/ml lysozyme solution and subsequent addition 
of P1 and P3 Qiagen buffers according to manufacturer’s instructions. After 
centrifugation cosmid DNA was precipitated by addition of 0.7 volumes of 
isopropanol, followed by centrifugation, and one wash with 70% ethanol. DNA 
was resuspended in 30 µl of TE pH 8.0 and stored at 4°C until use. 
 
Transfection of Toxoplasma 
Twenty five µg of cosmid library, single cosmid, PCR product or plasmid per 
transfection were precipitated by addition of 0.1 volumes of 3 M NaOAc and 2.5 
volumes of cold 100% ethanol. Freshly lysed parasites (109) resuspended in 
cytomix (Roos et al., 1994) were placed in 2 mm cuvette and electroporated with 
cosmid library respuspended in cytomix with 1.5 kV pulse, 24 Ω resistance, and 
25 µF capacitor settings of an BTX 830 electroporator (Harvard Apparatus). 
Electroporated parasites were transferred into T-175 or T25 flasks confluent with 
HFF cells and allowed to recover for 24 hrs at 35°C or 37°C. The stable 
transfectants, depending on the strain, were selected either at 35°C, 37°C, 40°C 
by addition of either 1 µM pyrimethamine (Donald and Roos, 1993) or 20 µM 
chloramphenicol acetyltransferase (CAT) (Kim et al., 1993b). 
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Plasmid rescue and sequence analyses 
Complemented parasites were harvested from a T-175 flask (~108 parasites), 
filtered through a 3 µm polycarbonate filter, and pelleted for 20 min at 1500 x g at 
4°C. Parasites were washed twice in 5 ml PBS followed (5 min at 3000 rpm in an 
Eppendorf micro-centrifuge). After washing, parasites were resuspended in 100 
µl TE and lysed by addition of 1% SDS, 4 µl of proteinase K (10 mg/ml), and 1 µl 
of RNase A (10 mg/ml) and incubated overnight at 55°C. DNA was isolated by 
two phenol/chloroform extractions, ethanol precipitated and resuspended in 50 µl 
deionized water. Two µg of DNA were digested with either BglII, HindIII, or XhoI 
at 37°C overnight. Digested DNA was purified using a PCR purification kit 
(Qiagen) and eluted in 30 µl elution buffer. Five µl of purifed DNA were ligated 
overnight with T4-DNA ligase at 16°C, ethanol precipitated, and resuspended in 
10 µl water. Five µl of the ligated DNA were electrophorated into 20 µl of DH12S 
electromax E. coli (Invitrogen) using a 1 mm gap cuvette with 1.8 kV pulse, 200 
Ω resistance, and a capacitor setting of 25 µF on a BTX 830 electroporator 
(Harvard Apparatus) followed by plating of the reaction on LB/Kan (50 µg/ml). 
DNA mini-preparations were performed on liquid cultures grown up from 
individual colonies (Qiagen) and the DNA digested with BglII and NotI at 37°C for 
4 hrs. The digests were run on 1% agarose gel containing ethidium bromide. 
Plasmid inserts of miniprep DNA were sequenced (Eurofins) using T3 primer. 
The sequences were BLAST searched against the annotated genome of the 
ME49 Toxoplasma strain through www.toxodb.org. Obtained sequences were 
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aligned to respective genomic regions using DNA Strider 1.4f8. Resulting 
alignments were considered as the region of the rescue. 
 
Genetic complementation with PCR products  
The individual genes from the complementing region on chromosome VI covered 
by the cosmid TOXOA93 were PCR amplified with these primer pairs; for 
49.m00063, 0063-F and 0063-R, 49.m03404, 3404-F and 3404-R, 49.m00062, 
0062-F and 0062-R ,and 49.m03405, 3405-F and 3405-R. PCR products were 
excised from gel and purified (Bioneer) followed by transfection into parasites. 
 
Identification of the point mutation in TgCactin 
The 5.7 genomic locus of TgCactin was amplified from the wild type RH strain 
and the FV-P6 mutant with 0063-F and 0063-R primers. The amplicons were gel 
purified using spin columns (Qiagen) and DNA eluted in 30 µl water. Sanger 
sequencing was performed by Agencourt Biosciences. To identify the point 
mutation the wild type and the FV-P6 sequences were aligned in DNA Strider 
1.4f8. 
 
Phylogeny 
Sequences were aligned using the CLUSTAL W algorithm (Thompson et al., 
1994) in the MegAlign program (DNA Star software) by using a neighbor-joining 
bootstrap method. The accession numbers of the Cactin genes used are: rat 
(NP_001074916), mouse (NP_081657), human (XP_002428222), fly 
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(NP_523422), worm (NP_496951), plant (NP_171887), Toxoplasma gondii 
(XP_002366927), Eimeria tenella (AI757514), Plasmodium knowlesi 
(XP_002257640), Plasmodium falciparum (XP_001349475), Plasmodium yoelii 
(XP_727028), Tetrahymena thermophila (XP_001024246), 
Schizosaccharomyces pombe (NP_595704), Cryptosporidium parvum 
(XP_626113), Leishmania major (XP_001684517), Trypanosoma brucei 
(CBH18183), Trypansoma cruzi (XP_810302). 
 
Sequence analysis of TgCactin 
Pfam database (http://pfam.sanger.ac.uk/; (Finn et al., 2010)) was searched to 
identify known domains within TgCactin. The nuclear signal localization was 
identified with the NLSdb application available on 
http://cubic.bioc.columbia.edu/db/NLSdb/ (Nair et al., 2003)). 
 
Microarray sample preparation 
Parasites were allowed to invade confluent HFF monolayers for 2 hrs at 35°C 
before the medium was aspirated and the cells washed twice with PBS. ED1 
medium was added, flasks were either left at 35°C or placed at 40°C and 
incubated for 24 hrs. Parasites were harvested by scraping of the monolayer, 
needle passing through 27-gauage needle, and filtering through a 3 µm 
polycarbonate filter. RNA was extracted using the RNeasy kit (Qiagen) including 
β-mercaptoethanol and DNase I treatment according to the manufacturer’s 
instructions. RNA quality was determined using the Agilent Bioanalyzer 2100. 
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RNA samples were sent to two different facilities for processing and hybridization 
(Michael White, Montana State University and Jeroen Saeij, MIT). Fragmented 
cDNA was hybridized to Toxoplasma gondii Affymetrix Gene Chip (ToxoDB). The 
hybridization data were processed with Robust Mutliarray Average (RMA) and 
normalized using internal controls.  
 
Bradyzoite assay 
HFF cells grown in 6-well plates with cover slips were infected with 300,000 
parasites, which were allowed to invade the host cells for 4 hours at 37°C. 
Subsequently, the medium was aspirated and replaced either with ED1 medium 
and grown under 5% CO2 (tachyzoite conditions) or replaced with Switch 
medium (0.01 g/ml RMPI, 0.018 g/ml Tricine, 1% FBS, and 0.5 mM 
Peniciline/Streptomycin, pH 8.1) and placed under ambient CO2 (bradyzoite 
conditions) for 24, 48 or 72 hrs. Samples were fixed with 100% methanol and 
processed for immunofluorescence assay.  
 
Mitochondrial staining 
HFF cells grown on cover slips in 6-well plates were infected with 100 µl of 
freshly lysed parasites and grown for 24 hrs at either 35°C or 40°C. The medium 
was replaced with MitoTracker Red CM-H2XRos (Invitrogen) at 1 µM in ED1 
medium and the cells were stained for 45 min as described (Lin et al., 2009). The 
medium was aspirated and the cells were washed 3x for 5 min with ED1 medium 
followed by 2x 5 min washes with PBS. Samples were fixed with freshly made 
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4% paraformaldehyde in PBS followed by 2 washes with PBS. The cells were 
permeabilized with 0.25% Triton X-100 in PBS for 20 min followed by 3 washes 
with PBS.  
 
Native Blue Gel Electrophoresis 
About 5 x 108 freshly lysed parasites were filtered through a 3 µm polycarbonate 
filter, counted, centrifuged for 20 min at 1500 x g at 4°C and washed 2x in 5 ml 
PBS. The samples were prepared and processed according to manufacturer’s 
instructions for the Native PAGE Novex Bis-Tris gel system (Invitrogen). In short, 
parasites were resuspended in 200 µl of lysis buffer (150 mM NaCl, 50 mM Tris-
Cl pH 7.5, containing either 1% Digitonin, 1% DDM, or 1% Triton-X-100 
detergents, and mammalian proteinase inhibitors (Sigma P8340)), syringe 
passed with 27-guage needle, and subjected to 5 min mild sonication in a water 
bath at 4°C. After sonication, the samples were treated with benzonase (2 U/200 
µl) and MgCl2 at a final concentration of 2 mM for 30 min at room temperature. 
After benzonase treatment, the lysate was centrifuged for 30 min at 4°C at 
13,000 rpm in a mini-centrifuge. After lysis, 30 µl of the sample was mixed with 
10 µl of 4x Native PAGE sample buffer and 0.5 µl of Native PAGE 5% G-250 
sample additive prior to loading on 4-16% gradient Native PAGE Novex Bis-Tris 
gel.  The inner chamber of the gel system was filled with Dark Blue cathode 
buffer and the outer chamber with Native PAGE running buffer. The samples 
were run at 150 V until the dye front migrated one third of the gel length. At this 
point the buffer in the inner chamber was replaced with Light Blue cathode buffer 
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and the gel run was continued at 150 V until the dye front reached the bottom of 
the gel. Subsequently the gel was transferred to polyvinylidene fluoride (PVDF) 
membrane in NuPAGE transfer buffer for 1 hr at 25 V at 4°C. The membrane 
post-protein transfer was then treated with 8% acetic acid for 15 min before 
Western blotting. 
 
Western blotting of samples  
Protein samples were loaded onto 12% NuPAGE Novex Bis-Tris gel (Invitrogen) 
and subjected to electrophoresis. Proteins were transferred to PVDF membrane 
at 300 mV for 70 min at 4°C. Following transfer, membranes were blocked in 
PBS containing 5% nonfat dry milk for one hour. Blocked membranes were 
incubated for one hour either with a rat monoclonal anti-HA Ab (3F10) (1:2,000; 
Roche) or a mouse monoclonal anti-myc Ab (9E10) (1:10,000; Santa Cruz 
Biotechnology). Blots were washed 3x 10 min with PBS containing 0.5% Tween-
20 before addition of horseradish peroxidase conjugated goat anti-rat (1:5,000) 
or goat anti-mouse (1:10,000) (DakoCytomation). Detection was done with 
enhanced chemiluminescence reagents (Amersham Biosciences). 
 
Yeast two-hybrid constructs 
All the clones generated in this section were made by the Gateway Technology 
(Invitrogen). In short, full-length wild type Cactin and full length FV-P6 Cactin 
were PCR amplified with AttB1-F-Cactin and AttB2-R-Cactin primers. Resulting 
amplicons were gel purifed and PCR amplified with universal AttB adapter 
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primers, Att-B1-adopt and Att-B2-adopt. Subsequently, the amplicons with 
complete attB sites were cloned by BP reaction into the pDONR201 vector, 
which reaction was transformed into chemically competent E. coli DH5α strain. 
100 µl of the transformation reaction was spread on LB/Kan plates. Positive 
clones of each insert were picked for LR reaction into pGBK-Att or pGAD-Att 
vectors (a kind gift of Michael White, Montana State Univ.). To limit the number of 
empty pGBK-Att vector containing transformants, ScaI was added to the LR 
mixture prior to spreading 100 µl on LB/Kan plates. On the other hand, 100 µl of 
the LR reaction mixture containing pGAD-Att was directly plated on LB/Amp 
plates. Cactin Clone# 7 (Exons 7-9 in pGAD-Att), which was identified through 
the YTH screen with pGBK-Cactin-BD, was cloned into pDONR201 through BP 
reaction and subsequently into pGBK-Att vector through LR reaction. 
 
Yeast two-hybrid procedures 
S. cerevisiae strain AH109 (MATa, trp1-901, leu2-3 , 112, ura3-52, lys2-181, 
his3-200, ade2-101, gal4-952, gal80-538, LYS2::GAL1uas-GAL1tata-HIS3, 
GAL2uas-GAL2tata -ADE2, URA3::MEL1uas-MEL1tata –lacZ) (Clontech) was 
grown at 30°C on a shaker to a cell density of 5x106 cells/ml. 45 ml of yeast 
culture was transferred to a 50 ml conical tube (Nalgene) and centrifuged for 5 
min at room temperature at 1,500 x g. The supernatant was discarded, 1 ml of 
sterile water was added to the pellet, which was subsequently resuspended by 
vortexing, transferred to a 1.5 ml Eppendorf tube and pelleted by pulsing at 6,000 
rpm. Water washing steps were repeated twice more. To the resulting pellet 1 ml 
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of 100 mM LiC2H3O2 was added followed by resuspension by vortexing, pelleting 
by pulse vortexing at 6,000 rpm in a mini-centrifuge, and removal of the 
supernatant. The pelleted yeast cells were resuspended in 4 volumes of 100 mM 
LiC2H3O2 followed by vortexing. For transformation, 50 µl of cells were 
transferred into a new 1.5 ml Eppendorf tube, followed by addition of 240 µl 50% 
polyetheline glycol (PEG) 3350 (Fisher) and 50 µl sheared salmon sperm DNA 
(Ambion). Finally, either 2.5 µg of bait plasmid was mixed with 1.0 µg of pGAD-x-
AD prey plasmid or the tachyzoite RH two-hybrid cDNA library (kindly provide by 
Michale White, State U. of Monatana (Kvaal et al., 2002). After 30 min incubation 
at 30°C in a water bath, 24 µl of sterile water was added and the reactions were 
heat shocked in a 42°C water bath for 15 min. Finally, the reaction mixtures were 
spun down for 10 sec at 5,000 rpm in a mini-centrifuge and the pellets were 
resuspended in 1 ml of sterile water by flicking. One hundred µl of the mix was 
plated out on SD/Trp-/Leu- plates and incubated at 30°C until appearance of 
colonies. Plates were then replica-plated to a quadruple-dropout selective 
medium (QDO) (SD/His-/Ade-/Trp-/Leu-). Growing colonies were patched onto 
new QDO plates, which were subsequently replica plated to QDO/X-α-Gal, 
QDO/3-aminotriazole at 5, 10, 25, and 50 mM. The colonies, which grew on 
QDO/X-α-Gal and at least on 10 mM QDO/3-aminotriazole plates were 
considered as strong interactions.  
DNA of prey plasmids was isolated from positive colonies grown overnight in 5 ml 
of QDO/Leu- medium 30°C using published methods (Hoffman and Winston, 
1987). In brief, cultures were spun down for 15 min at 7,000 rpm in a mini-
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centrifuge, the pellet was resuspended in 300 µl of Smash and Grab buffer (10 
mM Tris, 1 mM EDTA, pH 8.0) and transferred to Eppendorf tubes containing 
250 µl of 0.5 mm glass beads (BioSpec Products) and 300 µl of 
phenol/chloroform. The tubes were vortexed on a multi-tube vortexer (Beckman 
Coutler) for 3 min and spun down at 14,000 rpm for 3 min in a mini-centrifuge. 
About 300 µl of the aqueous phase from each sample was transferred to a new 
Eppendorf tube and ethanol precipitated for 20 min at -20°C. The resulting pellet 
was resuspended in 50 µl of sterile water. Four µl of the ”grabbed” DNA was 
transformed into chemically competent E. coli DH5α cells. Minipreps were 
screened by HindIII digestion and distinct clones sequenced using the T7 oligo 
as sequencing primer (Eurofins). Sequence results were analyzed by BLAST 
searching the Toxoplasma ME49 strain genome (www.toxodb.org). 
 
Protein isolation from yeast  
Protein isolation of Cactin fusion expressing yeast strains for western blotting 
was performed essentially as described (Humphrey et al., 1997). To isolate HA-
tagged prey proteins yeast cultures were grown in 5 ml of SD/Trp-/Leu- medium 
for 16 hrs at 30°C, spun down at room temperature for 15 min at 4,000 x g. The 
pellets were resuspended in 500 µl of the remaining supernatant. Subsequently, 
50 µl of 1.85 M NaOH and 1 µl of β-mercaptoethanol were added and mixed by 
vortexing, Samples were transferred to 1.5 ml Eppendorf tubes and incubated for 
10 min on ice. Proteins were precipitated by the addition of 50 µl 50% TCA, 
vortex-mixed and incubated on ice for 10 min. The samples were pelleted by 5 
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min centrifugation at 14,000 rpm in a mini-centrifuge. Pellets were  resuspended 
in one volume equivalent of 1 M Tris base pH 7.5 by vortexing. Insoluble debris 
was pelleted for 2 min at 14,000 rpm in a mini-centrifuge and the samples were 
loaded on 12% NuPAGE Novex Bis-Tris gel (Invitrogen), subjected to 
electrophoresis, transferred to PVDF membrane, and immunoblotted with the rat 
monoclonal anti-HA Ab (3F10) (1:2,000; Roche). 
To isolate Myc-tagged bait proteins yeast cultures were grown and processed 
according to the Yeast Protocol Handbook (Clontech). Yeast cultures were grown 
in 50 ml conical tubes (Nalgene) in SD/Trp-/Lue- medium at 30°C until the optical 
density at 600 nm (OD600) reached 0.6. Yeast cultures were pelleted by 
centrifugation at 4°C for 5 min at 1,000 x g in an Eppendorf centrifuge. Pellets 
were resuspended in about 400 µl of Cracking buffer (8 M urea, 5% SDS, 40 mM 
Tris-Cl pH 6.8, 100 µM EDTA, 0.01% of β-mercaptoethanol, 5 mM PMSF, and 1x 
mammalian protease inhibitors (Sigma P8340)), and 250 µl of 0.5 mm glass 
beads (BioSpec Products) prior to incubation at 70°C in the water bath for 10 
min. The exact volume of the Cracking Buffer was based on the OD600: 100 µl 
per 7.5 total OD600 in the pellet obtained from 50 ml of the yeast culture. 
Following incubation, the samples were vortexed vigorously for 2 min and 
pelleted by centrifugation at 4°C for 5 min at 7,000 rpm in a mini-centrifuge. The 
supernatants were transferred to new Eppendorf tubes and put on ice. The 
remaining pellets were boiled for 5 min in a heat block, vortexed and centrifuged 
as before. Supernatants were combined with the corresponding first supernatant 
and concentrated to 150 µl by using 10  kDa Microcon columns (Millipore).   
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Immunoprecipitation of Toxoplasma lysates 
Freshly lysed parasites (5 x 108) expressing tagged fusion proteins of interest 
were filtered through 3 µm polycarbonate filter, pelleted by centrifugation for 20 
min at 1500 x g at 4°C and washed twice in 5 ml PBS. Parasite pellets were 
resuspended in 500 µl modified RIPA buffer (135 mM NaCl, 1% Digitonin, 0.5% 
DOC, 0.05% SDS, 20 mM Tris pH 7.4, 10% glycerol, with 1x mammalian 
proteinase inhibitors (Sigma P8340)) and lysed on ice for 30 min with occasional 
mixing. The lysates were cleared by a 14,000 rpm at 4°C spin in a mini-
centrifuge. Subsequently, the soluble lysates were pre-cleared with 125 µl of 
plain agarose bead slurry (Invitrogen) for one hour at room temperature on a 
rotator in a spin column (Pierce). The eluates were subsequently mixed with 125 
µl of High Affinity HA matrix (Roche) by rotation for 4 hrs at room temperature in 
a Pierce spin column. The beads were washed 3x 5 min under rotating with the 
modified RIPA buffer followed by gravity flow draining . The sample was eluted 
by 3x with 50 µl of 0.5% SDS in PBS by boiling for 5 min followed by 
centrifugation at 14,000 rpm in a mini-centrifuge. Pooled eluates were stored at -
20°C until Western blotting. 
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